{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {},
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "document_metadata": {
      "authors": "Lingling Xu",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright Â© 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "DNSNP": "rs[0-9]+",
      "HBP": ".*",
      "TAXONOMY": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "INTERPRO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/interpro/interpro-20170731.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mesh-names.belns",
      "MGI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mgi-mouse-genes/mgi-mouse-genes-20170725.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "RGD": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/rgd-rat-genes/rgd-rat-genes-20170725.belns"
    },
    "namespaces_uncached": [],
    "path": "receptors/zoli2018.bel",
    "pybel_version": "0.13.3-dev"
  },
  "links": [
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Neuronal nicotinic acetylcholine receptors (nAChRs) belong to a super-family of Cys- loop ligand-gated ion channels that respond to endogenous acetylcholine (ACh) or other cholinergic ligands.",
      "key": "a2f923e09eae0918d941be86d3024986ddb1d0b14034e1a00dbe75980c41e6978b50406c47cbf233a84e0768248546c751bfeb6ba329062c0e8cffa5d1b1c2d2",
      "line": 64,
      "relation": "isA",
      "source": 72,
      "target": 68
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "In the brain, nAChRs are widely expressed, both presyn- aptically and postsynaptically, and are involved in several functions including learning and memory, arousal, reward, motor control, and analgesia. nAChRs are also the target of nicotine, the main addictive agent delivered by cigarette smoke",
      "key": "88d5636c521fd1137df841a66a502d53927f9574bd7d865bb38c9e84ab91df86dcdac89af969212f1d3b7ce3e2d044586fc279bc1cb83bd4516760b18f8456a9",
      "line": 99,
      "relation": "association",
      "source": 72,
      "target": 88
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "In the brain, nAChRs are widely expressed, both presyn- aptically and postsynaptically, and are involved in several functions including learning and memory, arousal, reward, motor control, and analgesia. nAChRs are also the target of nicotine, the main addictive agent delivered by cigarette smoke",
      "key": "2b8f0961cf302b623c1e1c3abf0bf05cf8662920b3afc9d83a96a0297b1e74f59413b8a784bb77f099f34ff1c115c493f78b92a5cba7792470eb50fb4b218043",
      "line": 100,
      "relation": "association",
      "source": 72,
      "target": 89
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "In the brain, nAChRs are widely expressed, both presyn- aptically and postsynaptically, and are involved in several functions including learning and memory, arousal, reward, motor control, and analgesia. nAChRs are also the target of nicotine, the main addictive agent delivered by cigarette smoke",
      "key": "677f30b51db634015165bc7ce842382c354b9924ebc93a55f034978653ef64d720dd454bcc03651af2436b8591065c61df138f53198a27cf0fb8a26dc75481db",
      "line": 101,
      "relation": "association",
      "source": 72,
      "target": 84
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "In the brain, nAChRs are widely expressed, both presyn- aptically and postsynaptically, and are involved in several functions including learning and memory, arousal, reward, motor control, and analgesia. nAChRs are also the target of nicotine, the main addictive agent delivered by cigarette smoke",
      "key": "2655103ba83afaa1d282d1b8f6176ef5328fa1fd4c3f939b55e141714009e23d7b07ea15cdf85475738781be844a86acedf7ab7619e5685a741869d0b10da906",
      "line": 102,
      "relation": "association",
      "source": 72,
      "target": 92
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "In the brain, nAChRs are widely expressed, both presyn- aptically and postsynaptically, and are involved in several functions including learning and memory, arousal, reward, motor control, and analgesia. nAChRs are also the target of nicotine, the main addictive agent delivered by cigarette smoke",
      "key": "0d231867dcb7e4f8bcb5491db75b85db17a092eff74453bed631ac3e339e8b9f98954c1ba5b29b75689e77d1373ced0dc76665505cc3771459c00914b4bd5bdc",
      "line": 103,
      "relation": "association",
      "source": 72,
      "target": 45
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs are expressed also at the somatodendritic postsynaptic site, where they regulate neuron depolarisation, firing and long- term potentiation [9]. Moreover these receptors are also in- volved in proliferation, differentiation and migration of neu- ral progenitors",
      "key": "e49d936563e428968345b8007fdb0eae25183fab9079bd336822ad8a172a11ce667dbb6983a18714d0f3043bb715a3d17f86e8f33e4c8aef107c59c1c73d1f58",
      "line": 123,
      "relation": "association",
      "source": 72,
      "target": 29
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs are expressed also at the somatodendritic postsynaptic site, where they regulate neuron depolarisation, firing and long- term potentiation [9]. Moreover these receptors are also in- volved in proliferation, differentiation and migration of neu- ral progenitors",
      "key": "50ef48b26750d97adf039c26cbd0c09d4e8ddec58a28e030974c5e89bef03898bbcafd8569bbae5d6355bad793b0ad504786c971c9bef50c9a548b74f616a44a",
      "line": 124,
      "relation": "association",
      "source": 72,
      "target": 36
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs are expressed also at the somatodendritic postsynaptic site, where they regulate neuron depolarisation, firing and long- term potentiation [9]. Moreover these receptors are also in- volved in proliferation, differentiation and migration of neu- ral progenitors",
      "key": "3b73bcecb2d29dc2abf3d818960fd0234402a4450f1f2bf2a77b60303fdba684bfc8ef9de522c66364ea9c308d567c6293dd51188cda1823259ef71cc5b6c85e",
      "line": 125,
      "relation": "association",
      "source": 72,
      "target": 31
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs contribute to cognitive function, and changes in their number and/or func- tion are associated with various pathological conditions such as cognitive disorders, anxiety, depression, Alzheimerâs and Parkinsonâs disease, pain and epilepsy ",
      "key": "c669a433b43e6c17ab677e962c591ac501890299db60f608814995f9fdc0a7bbe2ffc194854c441e5784179a1fcc4aea71581570aad50c3049aa32479e81a031",
      "line": 129,
      "relation": "association",
      "source": 72,
      "target": 79
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs contribute to cognitive function, and changes in their number and/or func- tion are associated with various pathological conditions such as cognitive disorders, anxiety, depression, Alzheimerâs and Parkinsonâs disease, pain and epilepsy ",
      "key": "5bc4f6033c5365ab4876b06ed801c0b185d7edbf7780d26d28ad5d161c7a2cd156061082eba08dddad85a4045cc7cadbe100c6fd1ff6fead10ac4fa4fb4cf50d",
      "line": 130,
      "relation": "association",
      "source": 72,
      "target": 83
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs contribute to cognitive function, and changes in their number and/or func- tion are associated with various pathological conditions such as cognitive disorders, anxiety, depression, Alzheimerâs and Parkinsonâs disease, pain and epilepsy ",
      "key": "5985fe4377cfcc5cc13b459d8f31073a99460850858f15be52559eed2db98b1aa47dd1c1cbf315fc8ee07d40db905914db021ab758f464bd360c7de92d988f9d",
      "line": 131,
      "relation": "association",
      "source": 72,
      "target": 85
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs contribute to cognitive function, and changes in their number and/or func- tion are associated with various pathological conditions such as cognitive disorders, anxiety, depression, Alzheimerâs and Parkinsonâs disease, pain and epilepsy ",
      "key": "a3b87da103198cc886c1f00a1f21972cbed3af5c4eba866d9085e44e156b90b3d5401b51bc8a0e51dedb4dbe802545e587b1f511011ed984719f208c1a35ba6c",
      "line": 132,
      "relation": "association",
      "source": 72,
      "target": 77
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs contribute to cognitive function, and changes in their number and/or func- tion are associated with various pathological conditions such as cognitive disorders, anxiety, depression, Alzheimerâs and Parkinsonâs disease, pain and epilepsy ",
      "key": "b2f559b398d15de4b0fc363a1a619332d417d858e704fc5bf0704843b0b38e00fbc82db5c6487a86b137dc2348f9d4c515b413e995688edb907f8029e993765c",
      "line": 133,
      "relation": "association",
      "source": 72,
      "target": 81
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs contribute to cognitive function, and changes in their number and/or func- tion are associated with various pathological conditions such as cognitive disorders, anxiety, depression, Alzheimerâs and Parkinsonâs disease, pain and epilepsy ",
      "key": "18320e6fb118b2740283443de3ab6805d8bb3b89732b4c4d9e02501aa9ab9ecf62ffac58944e4df929142664b84f1bc4b6c9d07cf803598f95325f37cee47f15",
      "line": 134,
      "relation": "association",
      "source": 72,
      "target": 91
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs contribute to cognitive function, and changes in their number and/or func- tion are associated with various pathological conditions such as cognitive disorders, anxiety, depression, Alzheimerâs and Parkinsonâs disease, pain and epilepsy ",
      "key": "ffa1e3db00248c9c3fa5d5ce6e672084d95f56b2e48ee0938f7daeaf56ad4b7728c4549e12c0dc3a67db71a80d8ab50c7994e480c2e3600cacc260f48f1929c6",
      "line": 135,
      "relation": "association",
      "source": 72,
      "target": 86
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs are particularly important in two critical periods of brain life: early pre- and post-natal circuit formation, and age-related cell degeneration. They are involved in neuronal survival, as it has been shown that nicotinic agonists are neu- roprotective in in vivo and in vitro models",
      "key": "471be9e3c69820db42a228a9fab7c3f6a36f4d3fd4e2ec5701126cdc405e535a6a764b2df1fdecd60bb0ebd686efd05603486d340728073a96cf3965a2204fc5",
      "line": 138,
      "relation": "association",
      "source": 72,
      "target": 23
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Dopamine (DA) neurons, which project to the NAc receive both excitatory glutamater- gic and cholinergic afferents that mediate nicotine reward, and inhibitory GABAergic afferents, that mediate aversion [77]. The release of these neurotransmitters is modulated by the nAChRs expressed in cholinergic, glutamatergic and GABAergic terminals ",
      "key": "c26a9ea3c626b2fedab61f416aaf6eb45a831fbca63a26b1c93a08cd5e2e9ffcbdf7fb311e2a4a9ac29212a9a4865262d81e5471dfbfbb57c42e872436808d76",
      "line": 166,
      "relation": "association",
      "source": 72,
      "subject": {
        "location": {
          "name": "GABAergic Neurons",
          "namespace": "MESH"
        }
      },
      "target": 3
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Dopamine (DA) neurons, which project to the NAc receive both excitatory glutamater- gic and cholinergic afferents that mediate nicotine reward, and inhibitory GABAergic afferents, that mediate aversion [77]. The release of these neurotransmitters is modulated by the nAChRs expressed in cholinergic, glutamatergic and GABAergic terminals ",
      "key": "db5b440c4cee6fc48df655b87b84e388874d78fe1c64a5216dae92a1446fd41811f19e2c7b58cf23d9ae1ac2e56adf712eb0c54ed2dc4621c6ef683fafb8e6eb",
      "line": 167,
      "relation": "association",
      "source": 72,
      "subject": {
        "location": {
          "name": "Cholinergic Neurons",
          "namespace": "MESH"
        }
      },
      "target": 3
    },
    {
      "key": "25eb4995df7e51ff1dd7607bab9f6f69900adc73be5133de1c2c951a0c6980f9b3cc811a8acc6b32245a5a5cd1136081def90b69e93d6c1c09fd7a1a6c60716a",
      "relation": "hasComponent",
      "source": 48,
      "target": 14
    },
    {
      "key": "65c5cfcf12b1755c87c68025bc3f9178c3462217073530586c25a2924d569443b039344dab69ff07518088aaca844009343a8b6844fd7bb6e939d0a26bbfbc42",
      "relation": "hasComponent",
      "source": 48,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The neurotransmitter acetylcholine (ACh) is synthesised, stored and released by cholinergic neurons, and exerts its effects on the central nervous system (CNS) and peripheral nervous system (PNS) through two distinct types of receptor: the muscarinic and nicotinic ACh receptors (mAChRs and nAChRs).",
      "key": "3d0c756637a7fef23944052f849dc45f6a191b70f605090ab100f95add32b80b03f82960d8d6557fa5025498ca8cd2b7471d11811a0b740ebe19c5361e861d78",
      "line": 73,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 48,
      "target": 12
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The binding of ACh or nicotine activates neuronal nAChRs thus leading to the influx of Na+ and Ca2+ and ef- flux of K+. ",
      "key": "ec6aba5f8a8703621832813b095d14e343e8be7b967e4aec413f911e99e48313d2ce010441f5cd6a3d0a185e2d81da4237fce078cd39d7e40b40e970a7713946",
      "line": 214,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "extracellular region",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "intracellular",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 48,
      "target": 26
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The binding of ACh or nicotine activates neuronal nAChRs thus leading to the influx of Na+ and Ca2+ and ef- flux of K+. ",
      "key": "1de99a5316ec872d724c595f7f32870814faabe85c1ed5e7eb16acf9d4acc22f23a3222fd00f64de8ef63b747c2bb0f37c6a5551e1949c8ce7817dccb1737246",
      "line": 215,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "extracellular region",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "intracellular",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 48,
      "target": 0
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The binding of ACh or nicotine activates neuronal nAChRs thus leading to the influx of Na+ and Ca2+ and ef- flux of K+. ",
      "key": "ce217ee0796a893a30743efd3607dd71441a2473de9d8625dc49eb52a4aa024b6eeee37a78d8a59478b3842a7752da933fc0030d9b0dc2a0ca97c07857b327d1",
      "line": 216,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "extracellular region",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 48,
      "target": 1
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "but ACh is also released by non-neuronal tissues where it is involved in cell-to-cell communication, and con- trols essential functions such as cell proliferation, adhesion, migration, secretion, survival and apoptosis, in an autocrine, paracrine or juxtacrine manner",
      "key": "d2d56c5c806aac6b1aa9a67f53086825b88db4fb4229a6fee1a9673a3cf6843ebd2aa1f61bf291f32135f48efaa0179979fd5d3e53bc3ecc761f91143562d286",
      "line": 76,
      "relation": "association",
      "source": 14,
      "target": 32
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "but ACh is also released by non-neuronal tissues where it is involved in cell-to-cell communication, and con- trols essential functions such as cell proliferation, adhesion, migration, secretion, survival and apoptosis, in an autocrine, paracrine or juxtacrine manner",
      "key": "85ae8870464350c0c3af946fdab9463a389f90a1f9e76f4d3aca9514c3f8e5f39897b9aa129f63ca301b118afcb6f5e151dc159257dc69273ef823b67854acc7",
      "line": 77,
      "relation": "association",
      "source": 14,
      "target": 36
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "but ACh is also released by non-neuronal tissues where it is involved in cell-to-cell communication, and con- trols essential functions such as cell proliferation, adhesion, migration, secretion, survival and apoptosis, in an autocrine, paracrine or juxtacrine manner",
      "key": "a738fbae9ea0291e773f2e446beac8a3f5072ca80e0f12323d824f97cb5f566312cc5e9918a58492d1e5dca1b56fd31e7fcceaaeb1138b930edd4d9d1d7113e1",
      "line": 78,
      "relation": "association",
      "source": 14,
      "target": 30
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "but ACh is also released by non-neuronal tissues where it is involved in cell-to-cell communication, and con- trols essential functions such as cell proliferation, adhesion, migration, secretion, survival and apoptosis, in an autocrine, paracrine or juxtacrine manner",
      "key": "7d623f47958ae164cd3b47d84d3c81e73027450d4602f77b350dd723c2ac43f6f54f3dcaf89a3ac2eb384b1bde94fe7e87dcef8a89bef654809b81a07f591c43",
      "line": 79,
      "relation": "association",
      "source": 14,
      "target": 40
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "but ACh is also released by non-neuronal tissues where it is involved in cell-to-cell communication, and con- trols essential functions such as cell proliferation, adhesion, migration, secretion, survival and apoptosis, in an autocrine, paracrine or juxtacrine manner",
      "key": "78d4fcf59bd478b8c97aaa787979815b44314e9f69dbae045de35506a03ded53fbd1dfbfd94a2aec3937de9cc018b79dab201d0fd2856338b49ea3451696f38c",
      "line": 80,
      "relation": "association",
      "source": 14,
      "target": 35
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "but ACh is also released by non-neuronal tissues where it is involved in cell-to-cell communication, and con- trols essential functions such as cell proliferation, adhesion, migration, secretion, survival and apoptosis, in an autocrine, paracrine or juxtacrine manner",
      "key": "39c3324d225c915eb86df1ef0f5544094bb73d9ed7487008207b93116fb755308b5196f06932505dee010dfaca0ffce67c5e87ed66fefd1219da36cd9fd4cab3",
      "line": 81,
      "relation": "association",
      "source": 14,
      "target": 42
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "but ACh is also released by non-neuronal tissues where it is involved in cell-to-cell communication, and con- trols essential functions such as cell proliferation, adhesion, migration, secretion, survival and apoptosis, in an autocrine, paracrine or juxtacrine manner",
      "key": "1fabc3e57f3046b58dd0c9812027c8f088925e5a509217382c27cf680e127c27dc21ef50c9a8d2230594ec3821ffca8379ebaa815b66a8f80e811e3d66b1cde8",
      "line": 82,
      "relation": "association",
      "source": 14,
      "target": 46
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "but ACh is also released by non-neuronal tissues where it is involved in cell-to-cell communication, and con- trols essential functions such as cell proliferation, adhesion, migration, secretion, survival and apoptosis, in an autocrine, paracrine or juxtacrine manner",
      "key": "61aa116aeb6d39814f68e7902ed190aeb7e73fd3872220a032f7e1caf1c9fca281a81df97076edd48b906ef4bce8aae7ef7c98de405dbf84612838af38c51691",
      "line": 83,
      "relation": "association",
      "source": 14,
      "target": 39
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "but ACh is also released by non-neuronal tissues where it is involved in cell-to-cell communication, and con- trols essential functions such as cell proliferation, adhesion, migration, secretion, survival and apoptosis, in an autocrine, paracrine or juxtacrine manner",
      "key": "59f8361c80db3172834949e30fc5fb4802d449967fb0f1ec8772c9f50c0e77c8fa0c8549e7158eaaa971039c8ccf605d024a7905d1692dae9316c269c336e14e",
      "line": 84,
      "relation": "association",
      "source": 14,
      "target": 44
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "but ACh is also released by non-neuronal tissues where it is involved in cell-to-cell communication, and con- trols essential functions such as cell proliferation, adhesion, migration, secretion, survival and apoptosis, in an autocrine, paracrine or juxtacrine manner",
      "key": "b237ad34897b34e06ec0cc4734a51939b206d266aa7dbccd3b26aa33c2c8d8a90e937850aad751012be574b96b88c5dc6ae1385ed45164c059e61ada251c2a99",
      "line": 85,
      "relation": "association",
      "source": 14,
      "target": 38
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Together with that re- leased by vagal nerve endings, ACh can also contribute to the cholinergic control of inflammation",
      "key": "c6a85138b5e8b5b1dc0cc03bcb72277c3f93f3cf42f54927a2c7920949da215a4e23058270c42bdf4ba4293cee543720a4043a3340857cf00b25e6804e2682ab",
      "line": 88,
      "relation": "decreases",
      "source": 14,
      "target": 87
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "When lung cancer arises from the airway epithelium, cell growth is stimulated by ACh or nicotine, and this growth loop may provide endogenous mitogenic signalling without any further activation ",
      "key": "9e5862791ac87d70ac9e1e7e8c13e9a5efbaf0fdd5a98b7fe51131bf8e7416ce29c7647163fb4ca89dcafff46e924c5a538d7461631658e406de7c6ff8724318",
      "line": 265,
      "relation": "increases",
      "source": 14,
      "target": 90
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Î±9 and Î±9-Î±10 nAChRs have a number of interesting characteristics: they are acti- vated by ACh but not by the classical agonist nicotine. Cho- line is also a potent selective agonist of the Î±9 subtype",
      "key": "9fe67afd32f0b5aa8dc8ed1b14c17c909b8ee2ff604c18fdeabdda2976d764fa4db3a1f1045ab658cf89ffc59887ad0b85cc663e42cb6521e0edeef68b435dd3",
      "line": 271,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 14,
      "target": 50
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Î±9 and Î±9-Î±10 nAChRs have a number of interesting characteristics: they are acti- vated by ACh but not by the classical agonist nicotine. Cho- line is also a potent selective agonist of the Î±9 subtype",
      "key": "e70d4905453a6a5a0343181dc5241bb71a8f5672b5a87605081a08d8a1109b393eca458d7fb51d27a9de4febe64d8e6e35af0b2be634cce9e92f74a164fe137f",
      "line": 273,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 14,
      "target": 63
    },
    {
      "key": "c6df5ce3222b6937117b848438da0ca3be0cfa3348726b5aafde791440abc238cdd7161da47e61f9c60c80ce397a045787756854281c425254b7421dd7868498",
      "relation": "hasComponent",
      "source": 49,
      "target": 24
    },
    {
      "key": "53bc1739fdcd1aca3458570f26b8b0509d135a83e7f965b92c9b838033c54c0cfe4f79a7b0e47dffc6886979aa6bf934eebc23f62c9b856f40443b266b49c684",
      "relation": "hasComponent",
      "source": 49,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Once in the bloodstream, nicotine, rapidly crosses the blood/brain barrier, and accumulates and exerts its pharmacological effects [9, 58] (including psy- chostimulation, reward and the reduction of stress and anxi- ety) in the brain by binding to nAChRs.",
      "key": "ad2b1307883664c614d7506a1f548cea9ef02167641656e7c566cd770a62373d005819d6a95b799699265f9e0a26b8edf16327be69ca5d1a95c7c779354a9a78",
      "line": 142,
      "relation": "decreases",
      "source": 49,
      "subject": {
        "location": {
          "name": "Brain",
          "namespace": "MESH"
        }
      },
      "target": 83
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": " Î±4Î²2* subtypes, in which the presence of different accessory subunits changes their pharmacological and biophysical properties, and their sensitivity to allosteric modulators and up-regulation by nicotine ",
      "key": "317818c0526ce47d99bac04a4f92de1b0508c676eb3c8d934182b6c91d7b4139e13edd701c29045bcf43deae32f25e2da20624441c1c47692c16c9632ec0076c",
      "line": 120,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 24,
      "target": 52
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": " By activating the Î±4Î²2 receptors on inhibitory GABAergic inputs to the VTA or GABAergic interneurons, smoked concentrations of nicotine transiently increase the release of GABA and subse- quently depress it for about one hour ",
      "key": "5b6cc2b3494c6e088a58efc3d726ddf2bf85f4cc62414171b4c75f19222554754bc6a8830b5ad4aea4efed87b888c3440b1548910e07851c9c1b21fd07786ecd",
      "line": 177,
      "relation": "increases",
      "source": 24,
      "target": 52
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Chronic nicotine treatment also activates the Î±7 receptors expressed on glutamatergic terminals, increases the release of glutamate (which facilitates the burst firing of VTA DA neurons), increases NMDA receptor activity, and LTP [79], but simultaneosusly induces the desensitisation of the Î±4Î²2 receptors on GABAergic terminals. Overall, these effects decrease the inhibition onto DA neurons, and increase DA release in the NAc [82].",
      "key": "1f2221d8aa3929ab0597cb566796c1df82fdfe74a92d7a42d76c19f618c3fbac99302ce3cbb179200c007d5876fa1e61ec18dc5b073c9a1531e9a1c5603b2fc1",
      "line": 191,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 24,
      "target": 52
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs are particularly important in two critical periods of brain life: early pre- and post-natal circuit formation, and age-related cell degeneration. They are involved in neuronal survival, as it has been shown that nicotinic agonists are neu- roprotective in in vivo and in vitro models",
      "key": "8dbc3b709e5f6dc5a8f9f084a963f485e6f52477276f85a52923ab7f6ee8ffb67d32277b60ede855d120233e82ec95f0973207733832308323fe424cf995bb13",
      "line": 139,
      "relation": "decreases",
      "source": 24,
      "target": 23
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Chronic nicotine exposure induces neural adaptations that change cell physi- ology and behaviour mainly as a result of activation and/or desensitisation of nAChRs. Studies of the brains of animals and smokers chronically exposed to nicotine have shown an increase in the number of nAChRs (up-regulation).",
      "key": "71cc74aba37cdaf635f2e44901949b637f2c642dfc20bf021500db7fd6c9b1c71d6d31df25ef5681357a9d1520af7906ec632407f5eff211233aac640cf82ab3",
      "line": 145,
      "relation": "decreases",
      "source": 24,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "There is evidence indicating that key steps in nicotine-induced up-regulation are receptor assem- bly [72, 73], decreased proteasomal degradation [74], traf- ficking [75] and cell surface expression ",
      "key": "b0614c62318a2200d46b4a4a93fc18a14669f01a2ded1ea854910cbe6c11b32287c55990fd72b5569c65450b33144e676806b2cf0993101800ccbdf859820f20",
      "line": 161,
      "relation": "increases",
      "source": 24,
      "target": 34
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "There is evidence indicating that key steps in nicotine-induced up-regulation are receptor assem- bly [72, 73], decreased proteasomal degradation [74], traf- ficking [75] and cell surface expression ",
      "key": "8a5a377acf6824ab919050376422c181c1b8f34b1dbee4a7da81c6decdb188100a61631ae1825790a594f4835225f7a8959406df8424132f5b4633c16bc189c9",
      "line": 162,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 24,
      "target": 69
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "By acting on the Î±7 receptors in glutamate terminals, acutely administrated nicotine stimu- lates the release of glutamate, which facilitates the burst fir- ing of VTA DA neurons and eventually leads to LTP,and increases the firing rate of the GABAergic neurons of the rostromedial tegmental nucleus",
      "key": "10ec4e69a68ccceb7aebcaa76eaee5516467528ddba180e9fe0f60b6982f0d168b6e01b77bba29f6f824a97b72d4c920b91b6e6e2da772901364f54c484e9d2f",
      "line": 172,
      "relation": "increases",
      "source": 24,
      "target": 20
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Chronic nicotine treatment also activates the Î±7 receptors expressed on glutamatergic terminals, increases the release of glutamate (which facilitates the burst firing of VTA DA neurons), increases NMDA receptor activity, and LTP [79], but simultaneosusly induces the desensitisation of the Î±4Î²2 receptors on GABAergic terminals. Overall, these effects decrease the inhibition onto DA neurons, and increase DA release in the NAc [82].",
      "key": "7944d23d03cd42024839f348c11829bb482ad175fd2d3d396a979e095fe28d3f61bdb31f3b53957482529245ad62cfbb408a9190732ac08861d8d808cdc4a333",
      "line": 188,
      "relation": "increases",
      "source": 24,
      "target": 20
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": " By activating the Î±4Î²2 receptors on inhibitory GABAergic inputs to the VTA or GABAergic interneurons, smoked concentrations of nicotine transiently increase the release of GABA and subse- quently depress it for about one hour ",
      "key": "834b21b476c2a32d65a1b1039f36c695516332a8fce7565cef3001d36d1b4e198041df5aa994a6293e75a2f52ea2794ba8f480e44a7f7902b749528d34509c79",
      "line": 178,
      "relation": "increases",
      "source": 24,
      "target": 70
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": " By activating the Î±4Î²2 receptors on inhibitory GABAergic inputs to the VTA or GABAergic interneurons, smoked concentrations of nicotine transiently increase the release of GABA and subse- quently depress it for about one hour ",
      "key": "b1da91a879df0f3d49bf4167b442b4a07fbc048b322ec2ef8b3d7159630126c3c2b95aa25d8546c9616582156fd51e4787d955a8f37287c1ce701c05751df5c7",
      "line": 179,
      "relation": "decreases",
      "source": 24,
      "target": 70
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nicotine modulates the shift towards burst firing and increases DA release in the NAc ",
      "key": "f8b54a8f05f470bd9ad4af92a2ec323d67672ae7324d90e13b049cf333e3d7c3008e611fdf975bcf26a4a239a63e149c6df2c9cdfeb62044bacec8d82b314383",
      "line": 182,
      "relation": "increases",
      "source": 24,
      "target": 29
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nicotine modulates the shift towards burst firing and increases DA release in the NAc ",
      "key": "bf3c80419c3ad46a828126dbc07440241276e21888b7822e94db628542104ea3f4fa829417f898d47e1f467e4762e82659d93cc92e1567ae447b0f92d68fee78",
      "line": 183,
      "relation": "increases",
      "source": 24,
      "target": 17
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Chronic nicotine treatment also activates the Î±7 receptors expressed on glutamatergic terminals, increases the release of glutamate (which facilitates the burst firing of VTA DA neurons), increases NMDA receptor activity, and LTP [79], but simultaneosusly induces the desensitisation of the Î±4Î²2 receptors on GABAergic terminals. Overall, these effects decrease the inhibition onto DA neurons, and increase DA release in the NAc [82].",
      "key": "65e2cfa99d104d65e39927a81eb7577de50f6ee3029654565a36b19fc258a60beeb676dc85054a40fd5d7b83f958498f7ac3c989bf91773ebd17c259eef2851c",
      "line": 192,
      "relation": "increases",
      "source": 24,
      "target": 17
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Chronic nicotine treatment also activates the Î±7 receptors expressed on glutamatergic terminals, increases the release of glutamate (which facilitates the burst firing of VTA DA neurons), increases NMDA receptor activity, and LTP [79], but simultaneosusly induces the desensitisation of the Î±4Î²2 receptors on GABAergic terminals. Overall, these effects decrease the inhibition onto DA neurons, and increase DA release in the NAc [82].",
      "key": "2dadc893ffd6c340df4b099ec3efe4b512881232cd5bf7faed4ac23ccc8d6004f81914db2b1a579b129f9a2d16dece11c28297c8d61e3fb5bd251c1922ad1013",
      "line": 187,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 24,
      "target": 62
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "These alterations are very similar to those observed in cul- tured human airway cells or in ex vivo human lung explants treated with the selective Î±7 antagonist Î±Bgtx, or epithelial cell cultures chronically exposed to nicotine in which nico- tine-induced desensitisation of Î±7 receptors mimics the ab- sence of Î±7 nAChR",
      "key": "5b920c75d08c4f4978d5c9df6b879ab3267e91bcd5e24c39b09a2e2be11d7657febfe8ef0429d70103732580071727be92bfb9add8395706e2dd088bd01dbf7d",
      "line": 261,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 24,
      "target": 62
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Chronic nicotine treatment also activates the Î±7 receptors expressed on glutamatergic terminals, increases the release of glutamate (which facilitates the burst firing of VTA DA neurons), increases NMDA receptor activity, and LTP [79], but simultaneosusly induces the desensitisation of the Î±4Î²2 receptors on GABAergic terminals. Overall, these effects decrease the inhibition onto DA neurons, and increase DA release in the NAc [82].",
      "key": "ae64e155b1e6ca8903c79dd78eb2a1dd4d601d65a3743d708df607839a971029008b3dd4a2f34fe9e5aaa77b402174bf2bbeaad2985d7772136964c789e38c9e",
      "line": 189,
      "relation": "increases",
      "source": 24,
      "target": 71
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Chronic nicotine treatment also activates the Î±7 receptors expressed on glutamatergic terminals, increases the release of glutamate (which facilitates the burst firing of VTA DA neurons), increases NMDA receptor activity, and LTP [79], but simultaneosusly induces the desensitisation of the Î±4Î²2 receptors on GABAergic terminals. Overall, these effects decrease the inhibition onto DA neurons, and increase DA release in the NAc [82].",
      "key": "53020891049017a617881fd34fb755bc72248b70ee445ec0ada1d4461ceb9528fff5f63a8d4bb9627183faaa5aa815e213c15882cec20654370c4e4751f69f51",
      "line": 190,
      "relation": "increases",
      "source": 24,
      "target": 43
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The coding SNP Î±5 D398N is closely associated with nicotine consumption ",
      "key": "aae14268a603ba66b8b21ca48953ff89865bb182bce38a28741989794950beab557ce1921ab50c5e07ba1b1cb9c059d97924693535c4e83d91b06ff7e0a7d482",
      "line": 201,
      "relation": "association",
      "source": 24,
      "subject": {
        "modifier": "Activity"
      },
      "target": 55
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "When lung cancer arises from the airway epithelium, cell growth is stimulated by ACh or nicotine, and this growth loop may provide endogenous mitogenic signalling without any further activation ",
      "key": "ef3245460ddb3722d96fcfd78e97096436f7f2b3bb3bdde98937381974d7fa92dc23a9f751406fab7e94d404654f62b6185481be21deb4329b344f18957c851a",
      "line": 264,
      "relation": "increases",
      "source": 24,
      "target": 90
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Î±9 and Î±9-Î±10 nAChRs have a number of interesting characteristics: they are acti- vated by ACh but not by the classical agonist nicotine. Cho- line is also a potent selective agonist of the Î±9 subtype",
      "key": "29efa3374d2fe08de24410f437c0921f265b2f5038bedba29141404aba2301b4bf3c9f8209e24732d54a08a2383c304efae78684612f411131cf7851c4a3488b",
      "line": 272,
      "object": {
        "modifier": "Activity"
      },
      "relation": "causesNoChange",
      "source": 24,
      "target": 50
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Î±9 and Î±9-Î±10 nAChRs have a number of interesting characteristics: they are acti- vated by ACh but not by the classical agonist nicotine. Cho- line is also a potent selective agonist of the Î±9 subtype",
      "key": "712def8e594426590896cc33a70ad4592e4375dfe82381fbc76a084cfc6c1364afa29684d2e57e6db5806ddee3c28d1fabc33fcbbde65f316e1caf0220ed86ee",
      "line": 274,
      "object": {
        "modifier": "Activity"
      },
      "relation": "causesNoChange",
      "source": 24,
      "target": 63
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The neurotransmitter acetylcholine (ACh) is synthesised, stored and released by cholinergic neurons, and exerts its effects on the central nervous system (CNS) and peripheral nervous system (PNS) through two distinct types of receptor: the muscarinic and nicotinic ACh receptors (mAChRs and nAChRs).",
      "key": "2b7f56434754c99fd334fa8161de629cb054ab1fa868d3e5d77e754b2bb4064efb8e12826c783a7402486daf268327e0a0ae7e0e38a5b12935c45f99fd29005e",
      "line": 71,
      "relation": "increases",
      "source": 6,
      "target": 14
    },
    {
      "key": "519b4f680cb25c51bb88fe964383b09050824bdfa56b7281119afa06f2d9a9a6ba5fd989259882379b4e93bf9ecb2b1d93e2c80368850d1351782c4e98725309",
      "relation": "hasComponent",
      "source": 47,
      "target": 13
    },
    {
      "key": "24ddcaa86d149bfe5d1f4bcab20c2076483b7c9c2d2bc43835e893ffcbcef7917d48c07ae7fda5529577b9f5665ce5c24ddf6216d72122008da02920975baab6",
      "relation": "hasComponent",
      "source": 47,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The neurotransmitter acetylcholine (ACh) is synthesised, stored and released by cholinergic neurons, and exerts its effects on the central nervous system (CNS) and peripheral nervous system (PNS) through two distinct types of receptor: the muscarinic and nicotinic ACh receptors (mAChRs and nAChRs).",
      "key": "e42dcb3a328211f44d5526df5be29a5fd3eb7a273358230c814733b3da35e11c45b271af68d475e1837bf07426829dae3901ce8a98ba26711a86a19b045ce60c",
      "line": 72,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 47,
      "target": 4
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "but ACh is also released by non-neuronal tissues where it is involved in cell-to-cell communication, and con- trols essential functions such as cell proliferation, adhesion, migration, secretion, survival and apoptosis, in an autocrine, paracrine or juxtacrine manner",
      "key": "34d48fc5751bdc314ed30577f89a3585357758b0b6c97ada649f14a186955baf7443521511ce023303a67ac5bc48b76173315b352d68837ae7651828fff24273",
      "line": 76,
      "relation": "association",
      "source": 32,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "but ACh is also released by non-neuronal tissues where it is involved in cell-to-cell communication, and con- trols essential functions such as cell proliferation, adhesion, migration, secretion, survival and apoptosis, in an autocrine, paracrine or juxtacrine manner",
      "key": "6f1249ef67adf908887c46f77f099b28b62fe86aaecc55e2917d6890f9be8428669621b7ca5416809174a5bb699ca120b43ab9eee8a594227b0413848300b4c4",
      "line": 77,
      "relation": "association",
      "source": 36,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs are expressed also at the somatodendritic postsynaptic site, where they regulate neuron depolarisation, firing and long- term potentiation [9]. Moreover these receptors are also in- volved in proliferation, differentiation and migration of neu- ral progenitors",
      "key": "81181caccbe18db8a3f7c9490adcc54f079e4a868f24932073ba365cb6768baa481b38b7e94a85e5ca19bae7a539fd75a8badca4adbe9633166a4387b42aebfc",
      "line": 124,
      "relation": "association",
      "source": 36,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "but ACh is also released by non-neuronal tissues where it is involved in cell-to-cell communication, and con- trols essential functions such as cell proliferation, adhesion, migration, secretion, survival and apoptosis, in an autocrine, paracrine or juxtacrine manner",
      "key": "89881708f38db9bca47dc5d61842fcd27b772df036fc2fd00dada546e691f2fdc1e15fbe979fa0236ba86b0f02b1ca227402571443522424819cf0ac1091187b",
      "line": 78,
      "relation": "association",
      "source": 30,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "but ACh is also released by non-neuronal tissues where it is involved in cell-to-cell communication, and con- trols essential functions such as cell proliferation, adhesion, migration, secretion, survival and apoptosis, in an autocrine, paracrine or juxtacrine manner",
      "key": "fe0ed0e35d3313081ca58546f8db7c97b9d0445464e527f62f8b704913f70e36dbef6ed7da8f46183dec0926bff4163a760bda3e1e3361348b5660d5f227f736",
      "line": 79,
      "relation": "association",
      "source": 40,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "but ACh is also released by non-neuronal tissues where it is involved in cell-to-cell communication, and con- trols essential functions such as cell proliferation, adhesion, migration, secretion, survival and apoptosis, in an autocrine, paracrine or juxtacrine manner",
      "key": "e7a26ec7604aaabd69bb2ea5ddca9d3ac773d43865442822adb46e7e489f49f33f2b6745c2226293d1f13798dd8771707a8e4a01fac11fb82259c765d04ea561",
      "line": 80,
      "relation": "association",
      "source": 35,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "but ACh is also released by non-neuronal tissues where it is involved in cell-to-cell communication, and con- trols essential functions such as cell proliferation, adhesion, migration, secretion, survival and apoptosis, in an autocrine, paracrine or juxtacrine manner",
      "key": "8ca40b3594cdf2c77fac1d914c7ead59c905c50237cf18f7166acb469bc9b553f54ffd57a01ee0ae78e5a5c4dbc95b974ca6ecdde9e426a2b4cef49412231872",
      "line": 81,
      "relation": "association",
      "source": 42,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "but ACh is also released by non-neuronal tissues where it is involved in cell-to-cell communication, and con- trols essential functions such as cell proliferation, adhesion, migration, secretion, survival and apoptosis, in an autocrine, paracrine or juxtacrine manner",
      "key": "9dfda80c2e1191d47f8354cd22cea57f70ea8dd238b11ffe1c76acadfaa9556abc2f40c6bf8d501b45de7c57366882285484face7d54d398ea5e2f17d58de170",
      "line": 82,
      "relation": "association",
      "source": 46,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "but ACh is also released by non-neuronal tissues where it is involved in cell-to-cell communication, and con- trols essential functions such as cell proliferation, adhesion, migration, secretion, survival and apoptosis, in an autocrine, paracrine or juxtacrine manner",
      "key": "b68d5d6b90d77341ec71e4cc9f7a4dfc33aa715139a0a9a047073b9286da32304b1e438e6f46bc22e2e39b6a3b3a3dc4f01e1d72887e2d150571c49d9cbbe3e6",
      "line": 83,
      "relation": "association",
      "source": 39,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "but ACh is also released by non-neuronal tissues where it is involved in cell-to-cell communication, and con- trols essential functions such as cell proliferation, adhesion, migration, secretion, survival and apoptosis, in an autocrine, paracrine or juxtacrine manner",
      "key": "d5a68109f1870352fc656861dd242135a9f4226ed6348341284d9a6feb160ce6ee249403dab8c5ddbd4791464d6db96b5be898601976677068cf0267aa4e41be",
      "line": 84,
      "relation": "association",
      "source": 44,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "but ACh is also released by non-neuronal tissues where it is involved in cell-to-cell communication, and con- trols essential functions such as cell proliferation, adhesion, migration, secretion, survival and apoptosis, in an autocrine, paracrine or juxtacrine manner",
      "key": "59b52e4dfed506da40ece51ad12891a2b1dcd1fed9a1d9f723780a96ac638ef826bce52354e9a861bcec4006feafc1c2114ee83362e4821e6ad1ed02008d3f61",
      "line": 85,
      "relation": "association",
      "source": 38,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Accordingly, ACh and its synthesizing enzyme choline acetyltransferase (ChAT), are found in human and animal erythrocytes, immune cells, endothelial and epithelial cells (including airway epithelial cells) and placenta cells. Small amounts of ACh are even found in blood ",
      "key": "1d0de18aada40737aed5759d4d5080c42633b44d680dd705126c699e5af12b6c5f841316ec62c9769f23086c997c54d7946a541618d690c984548e496995cdc4",
      "line": 91,
      "relation": "increases",
      "source": 19,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Accordingly, ACh and its synthesizing enzyme choline acetyltransferase (ChAT), are found in human and animal erythrocytes, immune cells, endothelial and epithelial cells (including airway epithelial cells) and placenta cells. Small amounts of ACh are even found in blood ",
      "key": "db1de9a312aa7e110b1e52fa95aeaa7faffa898b131ca873a7cd2939e0fe3dba7bb74df4463490f7ad8078a37a6604831244114af929a7958af49154838da034",
      "line": 94,
      "relation": "increases",
      "source": 19,
      "target": 5
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Accordingly, ACh and its synthesizing enzyme choline acetyltransferase (ChAT), are found in human and animal erythrocytes, immune cells, endothelial and epithelial cells (including airway epithelial cells) and placenta cells. Small amounts of ACh are even found in blood ",
      "key": "1650f87506f745f1d6bdf01e6c6c162f86397052731c579dd8d79f7853ed4af434b515fa29db681a7a269cb225f315ebe774745d957e186deae3e435568f4800",
      "line": 92,
      "relation": "increases",
      "source": 9,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Accordingly, ACh and its synthesizing enzyme choline acetyltransferase (ChAT), are found in human and animal erythrocytes, immune cells, endothelial and epithelial cells (including airway epithelial cells) and placenta cells. Small amounts of ACh are even found in blood ",
      "key": "ba9246ac044cbba54bf5303686284c921175f759a36b30ea08b7e509316fdf2c0c8e2afda1e18811db3e13757c10c1bcbf9040b4d42ae30bfae4ca543e802e0f",
      "line": 95,
      "relation": "increases",
      "source": 9,
      "target": 5
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Accordingly, ACh and its synthesizing enzyme choline acetyltransferase (ChAT), are found in human and animal erythrocytes, immune cells, endothelial and epithelial cells (including airway epithelial cells) and placenta cells. Small amounts of ACh are even found in blood ",
      "key": "c066b539bc9bf5f462bb5274b2270b1a8c65ba575eebb8658abde9dcb113f2be5c23fa3c6133af19e1f8ef53e5291c6cdd61daf51e2b3f7685e1be9c9a6f64b5",
      "line": 93,
      "relation": "increases",
      "source": 10,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Accordingly, ACh and its synthesizing enzyme choline acetyltransferase (ChAT), are found in human and animal erythrocytes, immune cells, endothelial and epithelial cells (including airway epithelial cells) and placenta cells. Small amounts of ACh are even found in blood ",
      "key": "5eaa24a26b03681944579d967f0a81232c20e0d857d23383573d4884a1ce7ccda7065b3dc0764c1dd3ca2ed6e37a474f73b074c96fd8339edab1708c14d9669e",
      "line": 96,
      "relation": "increases",
      "source": 10,
      "target": 5
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "In the brain, nAChRs are widely expressed, both presyn- aptically and postsynaptically, and are involved in several functions including learning and memory, arousal, reward, motor control, and analgesia. nAChRs are also the target of nicotine, the main addictive agent delivered by cigarette smoke",
      "key": "8a4cd18f2f4ebd3c3260ad9e7574030667f5953ff035406151ad32c6c1f30fd6789a5ef90bd824c120e9cb966cc1e13baf7b34093fbbb64b65dfbc6da44b0509",
      "line": 99,
      "relation": "association",
      "source": 88,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "In the brain, nAChRs are widely expressed, both presyn- aptically and postsynaptically, and are involved in several functions including learning and memory, arousal, reward, motor control, and analgesia. nAChRs are also the target of nicotine, the main addictive agent delivered by cigarette smoke",
      "key": "cfeee0af7508b7290bdb198e952f4b60b34e215843bd01e15aaa3a661e896e74a137826311f28716d4f0b967bf0e61ac2e72095faf7ad3c9573f014cda92ae5c",
      "line": 100,
      "relation": "association",
      "source": 89,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "In the brain, nAChRs are widely expressed, both presyn- aptically and postsynaptically, and are involved in several functions including learning and memory, arousal, reward, motor control, and analgesia. nAChRs are also the target of nicotine, the main addictive agent delivered by cigarette smoke",
      "key": "0b79680e87b1dc3efa835383396a3407c97755ab7ec46b7dd2943ffaa888faf801fc011128ed5e0b8bfba9895578a4401f9ad6e5e57a2ce028abc85805efdf07",
      "line": 101,
      "relation": "association",
      "source": 84,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "In the brain, nAChRs are widely expressed, both presyn- aptically and postsynaptically, and are involved in several functions including learning and memory, arousal, reward, motor control, and analgesia. nAChRs are also the target of nicotine, the main addictive agent delivered by cigarette smoke",
      "key": "7fda5815b845954d48f017e5a08c6efdfcde20ad31800a1ce8535dddec5c83db656d8fe9bf470e004533b9cd995eb9369c654c6d461afd7041e9105ffb622f44",
      "line": 102,
      "relation": "association",
      "source": 92,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "In the brain, nAChRs are widely expressed, both presyn- aptically and postsynaptically, and are involved in several functions including learning and memory, arousal, reward, motor control, and analgesia. nAChRs are also the target of nicotine, the main addictive agent delivered by cigarette smoke",
      "key": "0648963ad72affb3721e2a32a5e43b2e84b3b9efeca5b803621a690af5abfc26ca4a2d757f3254ac6afa40b85dac60ae8f27af4c425c043d9f7bb754dd42c430",
      "line": 103,
      "relation": "association",
      "source": 45,
      "target": 72
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Î±7-containing receptors are expressed in neurons and non-excitable cells in order to mediate pro-proliferative, sur- vival and anti-inflammatory signalling.",
      "key": "e5a6ae4c63f15e93b6fd81ebb43518b19d0534ad65881198487783fd146e46780ce18ea2dfe986fc5a9604967d347573d7430f53bd60de701e3b2cf6cf81e0c2",
      "line": 238,
      "relation": "regulates",
      "source": 62,
      "target": 42
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Î±7-containing receptors are expressed in neurons and non-excitable cells in order to mediate pro-proliferative, sur- vival and anti-inflammatory signalling.",
      "key": "1d3be4018c43bed0d7592b78c6784f06711f467b5f549d61989af5134f4087feeb1a976b20cdf847fec7b6b4a83127df21c8fb1b6af4945069c9c1e7b29b27a8",
      "line": 239,
      "relation": "regulates",
      "source": 62,
      "target": 87
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "In addition, various studies have shown the expression of Î±7 nAChR (as mRNA and protein), in many different cancer cells obtained from human tumours.",
      "key": "cef0db857a2c540f8836820ee6f6aee70b69b7499fa70df3c088b5702e3b9d3b88c3195ba70298e9630daef0d08e4ea6cf2edc2f4498dd75344915b5bbd46d0b",
      "line": 242,
      "relation": "association",
      "source": 62,
      "target": 90
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": " it has recently been shown that the intra- cellular loop of the Î±7 subunit contains a G protein binding cluster that promotes intracellular signalling",
      "key": "9eb732a5cc6f8767bcd6ec7bb28c21934e802c5e5d2933c997fb9d27fe89dca26f0fb756b5a94be55c1573c80c354f5e4b578b0a0fafd0d775bd5e9072e4fe90",
      "line": 245,
      "relation": "increases",
      "source": 62,
      "target": 33
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "whereas those on microglia increase intracellular calcium levels and signalling cascades without using channel function, and those on macrophages and other immunological cells signal through the JAK2/STAT3 tran- scription factor pathway",
      "key": "61477f335f7c296337648fda1f0cf5012689df8443304aaf5dcc297da446cfd7225bcbe5da8b049ce02ea6167dc68a2e856b563c1d85269ef74360b3660080d6",
      "line": 248,
      "relation": "increases",
      "source": 62,
      "target": 28
    },
    {
      "key": "46340e431ecf783a6cfc1f613d8ab61bf0165010d577be3fd0ea0454a24ec26ea2f17ef2bf858382add8c3accc7c8f783ec4f6ac3c4f4b054f213aab2bcad2e1",
      "relation": "hasComponent",
      "source": 53,
      "target": 61
    },
    {
      "key": "a48d08636505dfcdbbc66dda758308edfb0cbaac2dad9ba721f0e53556e76e8d2ce069b6ed27d8127de88bc04fc1251152b0f193e1e228be2d94e32e3235cb3a",
      "relation": "hasComponent",
      "source": 53,
      "target": 62
    },
    {
      "key": "fa54295cda944e6ba49054c092d030fc4236f3479f09a9d924156362f109b20e5ecdbcb933ab2db6c3591c18abdd839ca6cfbd4bb15f608e89d34f312239ef85",
      "relation": "hasComponent",
      "source": 53,
      "target": 64
    },
    {
      "key": "a23ab49ac682cee2c93c6901953e08b4b3e37c2c50ada6894d7dc6ee751c5d21e61ec47affbc2eb13326fd3a7042907ef5c1c88d753da3b9822895b66458554f",
      "relation": "hasComponent",
      "source": 53,
      "target": 65
    },
    {
      "key": "f27f37cdd83434bfdf226a0b2a71a61363f3bdf84094cd98096f790d2fd0645ff3ad8129ececcb653011fa5a381067b59cde521f4bdf87889dadf74cc8ed543e",
      "relation": "hasComponent",
      "source": 53,
      "target": 66
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Functional studies have shown that Î±7dup, expressed in oo- cytes, acts as a dominant negative regulator of Î±7 nAChR activity by means of a mechanism involving a reduction in the number of functional Î±7 nAChRs incorporated into the oocyte surface ",
      "key": "1faab8d4ab8e5e245e956b378b87584b6dd53cdfead8df1b1600129a62cb8840a2b6a44c6c3353257f49ffb43a976c7482ca6c49354f33ea7f892e43ac369e22",
      "line": 117,
      "object": {
        "location": {
          "name": "Oocytes",
          "namespace": "MESH"
        },
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 57,
      "subject": {
        "location": {
          "name": "Oocytes",
          "namespace": "MESH"
        }
      },
      "target": 62
    },
    {
      "key": "4e1a057c746665f5f9a1ef5f7cb55cca4a846183d1fdf51fb946be04dc68922d6707cba1f308a3f8bed826faa7a7ac091cfdcaa785ad11e3f1103f87ff75228a",
      "relation": "hasComponent",
      "source": 52,
      "target": 60
    },
    {
      "key": "aae43c9e88eb8c7018e403f5882f818acbbde1d8580bc5ef238d29f1995e5adf24d59c3651561e1cfd059750d237b43e16aed54e029890a7d56185667945ae96",
      "relation": "hasComponent",
      "source": 52,
      "target": 64
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs are expressed also at the somatodendritic postsynaptic site, where they regulate neuron depolarisation, firing and long- term potentiation [9]. Moreover these receptors are also in- volved in proliferation, differentiation and migration of neu- ral progenitors",
      "key": "a7d21cf4f2047324baaaeb8537aaead4dd52a3c562e296e1c496623b627dde44c619d17634433ccb9392ab0ebfb445612d578fe2487fa248fa179944d7ce5ec8",
      "line": 123,
      "relation": "association",
      "source": 29,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs are expressed also at the somatodendritic postsynaptic site, where they regulate neuron depolarisation, firing and long- term potentiation [9]. Moreover these receptors are also in- volved in proliferation, differentiation and migration of neu- ral progenitors",
      "key": "391c33835aa761997c89c65245bb55e88547f2185a10786b0e203ee1df0e64a3568590be6dc021c523d7e48cde6603b3ebeffdd149ab6c72232330285e677256",
      "line": 125,
      "relation": "association",
      "source": 31,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs contribute to cognitive function, and changes in their number and/or func- tion are associated with various pathological conditions such as cognitive disorders, anxiety, depression, Alzheimerâs and Parkinsonâs disease, pain and epilepsy ",
      "key": "21eb9fe848d8fa673e9c2dd13006ba1727140a19c5520d3ea8f95bf47f592a82ddfe7b3c5d85aea0f3627acaeef78412d722bdf2414253ec3de367d39104840c",
      "line": 129,
      "relation": "association",
      "source": 79,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs contribute to cognitive function, and changes in their number and/or func- tion are associated with various pathological conditions such as cognitive disorders, anxiety, depression, Alzheimerâs and Parkinsonâs disease, pain and epilepsy ",
      "key": "88699687146610d45759d8e8ca43248410eade1e0160ecaf6cbb8861d4ffefff67a2e43d728788e17de50b63410761a703874dd62fbfb72f676e5662694c7e1e",
      "line": 130,
      "relation": "association",
      "source": 83,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs contribute to cognitive function, and changes in their number and/or func- tion are associated with various pathological conditions such as cognitive disorders, anxiety, depression, Alzheimerâs and Parkinsonâs disease, pain and epilepsy ",
      "key": "5d20ff795780caa5e86f5eeac23bfc88841ffa3ea9f80636762b7850c9ab4dd797c238aa6bc5ccd23f114aebd5e11c6f2412f7fc73a239b83c06ee62ed869b25",
      "line": 131,
      "relation": "association",
      "source": 85,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs contribute to cognitive function, and changes in their number and/or func- tion are associated with various pathological conditions such as cognitive disorders, anxiety, depression, Alzheimerâs and Parkinsonâs disease, pain and epilepsy ",
      "key": "67f6fd6ad6a312a930dc52fd734d315ccb2402329fa2e0e5df1d9d820e70479f1d7b1ea5ba93db2d022f4648fd5ff1896858bf56343a0a8113213bcd6da9b757",
      "line": 132,
      "relation": "association",
      "source": 77,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs contribute to cognitive function, and changes in their number and/or func- tion are associated with various pathological conditions such as cognitive disorders, anxiety, depression, Alzheimerâs and Parkinsonâs disease, pain and epilepsy ",
      "key": "2a977e4c49dbc150d7a9cfa6b2aeaa6047a00596ca58fc342bfc695af7fdba1f89b9e7f8e84c0c3b9d9a166b66d2d55f26ef6b5df46156380e1ab93ea78c0045",
      "line": 133,
      "relation": "association",
      "source": 81,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs contribute to cognitive function, and changes in their number and/or func- tion are associated with various pathological conditions such as cognitive disorders, anxiety, depression, Alzheimerâs and Parkinsonâs disease, pain and epilepsy ",
      "key": "a25d7affb8da81316b64c46e7912bbccd7891a4fb51644cb6de0f33edd459e2dd87037d9696c71bc86fe986b7ceee78b0d0d034d7041d4c283efd363f0784374",
      "line": 134,
      "relation": "association",
      "source": 91,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs contribute to cognitive function, and changes in their number and/or func- tion are associated with various pathological conditions such as cognitive disorders, anxiety, depression, Alzheimerâs and Parkinsonâs disease, pain and epilepsy ",
      "key": "e59e5ade944f2c42a6ec519a73f20953a9aab5b9190021ec3a854bf522fc6865c4637a432689db122e72aee0342efa236e8c0bd269b2e981c3133f5eadfd0c57",
      "line": 135,
      "relation": "association",
      "source": 86,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "nAChRs are particularly important in two critical periods of brain life: early pre- and post-natal circuit formation, and age-related cell degeneration. They are involved in neuronal survival, as it has been shown that nicotinic agonists are neu- roprotective in in vivo and in vitro models",
      "key": "351394a43bee43893ff7ad9a9962a87be7646d63729b2248940bda8657e06d6c4a8bef0d5b27155f6d4dc479404453b78eb5dfcd4e60953af359816a38f17ca6",
      "line": 138,
      "relation": "association",
      "source": 23,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The up- regulation of nAChRs has also been obtained using nicotinic agonists (cytisine, carbamylcholine and varenicline) [66, 67], antagonists (dihydro-Î²-erythroidine, mecamylamine) [68-70] and a partial agonist (CC4) ",
      "key": "4f39b6ecf01035366a93c3d583bf201cc79e67dfd8f90e34be7b9f8abd97656adfdff4738721dadd77f472e03ca0351b58d31e3c0240e08fdb1b01bb3c952fe0",
      "line": 148,
      "relation": "decreases",
      "source": 2,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The up- regulation of nAChRs has also been obtained using nicotinic agonists (cytisine, carbamylcholine and varenicline) [66, 67], antagonists (dihydro-Î²-erythroidine, mecamylamine) [68-70] and a partial agonist (CC4) ",
      "key": "1f4f797aa70dd105a5e61e3820006d2135afdab456b3e234104669f6c7afa0f91cabf47684f3cb17f27d86a44c08fe68bb21cee7e7186ead5ebeaed797b97135",
      "line": 153,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 2,
      "target": 24
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The up- regulation of nAChRs has also been obtained using nicotinic agonists (cytisine, carbamylcholine and varenicline) [66, 67], antagonists (dihydro-Î²-erythroidine, mecamylamine) [68-70] and a partial agonist (CC4) ",
      "key": "d6d5fb84accc345ce3bb4e51417e3700dd379fc8fd05d9e727a1b8694f6ddb738f49b2e5dddf8326a45f4194d0d8968c9571acc0f25eca936fe2507764b29d1a",
      "line": 149,
      "relation": "decreases",
      "source": 15,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The up- regulation of nAChRs has also been obtained using nicotinic agonists (cytisine, carbamylcholine and varenicline) [66, 67], antagonists (dihydro-Î²-erythroidine, mecamylamine) [68-70] and a partial agonist (CC4) ",
      "key": "a41e2c6224b7a08e309a169ff40a0694ae15d98308cc951e55270976a08d555d30d0efd1f30969bdb50c120b5ef72ebc531bddd6b74db32ec804ae03baf0752e",
      "line": 154,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 15,
      "target": 24
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The up- regulation of nAChRs has also been obtained using nicotinic agonists (cytisine, carbamylcholine and varenicline) [66, 67], antagonists (dihydro-Î²-erythroidine, mecamylamine) [68-70] and a partial agonist (CC4) ",
      "key": "7c920fcd142503d0d2ae3721e491c4c67af0e32cf4d58a36832ea178c71c98b201bb2284fe6b53477eeab17390c9f2abf4e48478f2d8ee094808b10783dd2e5c",
      "line": 150,
      "relation": "decreases",
      "source": 27,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The up- regulation of nAChRs has also been obtained using nicotinic agonists (cytisine, carbamylcholine and varenicline) [66, 67], antagonists (dihydro-Î²-erythroidine, mecamylamine) [68-70] and a partial agonist (CC4) ",
      "key": "7b8002efbe3809c3dadcc9d356ea2b96fc884153ddcfe8ba0b3a9b1f8c21711f9594e4e650527bb646d36a0e89158e1f78e2534139785ba7a7654e01f43bf5e9",
      "line": 155,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 27,
      "target": 24
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The up- regulation of nAChRs has also been obtained using nicotinic agonists (cytisine, carbamylcholine and varenicline) [66, 67], antagonists (dihydro-Î²-erythroidine, mecamylamine) [68-70] and a partial agonist (CC4) ",
      "key": "5cc7baf297d75271be7fae090b7bf9b7929526d4f174f9f1b708b92913de060a78c4a114cf17a32bebbc68e37d498bcb25d388cfeefe8b36e72d33216e982b74",
      "line": 151,
      "relation": "decreases",
      "source": 7,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The up- regulation of nAChRs has also been obtained using nicotinic agonists (cytisine, carbamylcholine and varenicline) [66, 67], antagonists (dihydro-Î²-erythroidine, mecamylamine) [68-70] and a partial agonist (CC4) ",
      "key": "7ce24b90ae1f5c49a11242d92f308f08a05e997e42961477def35c4f6e65a5db191e49aaa84c87b77151452193ccd1bce4b132d41bb6fab53b5e868549f120db",
      "line": 156,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 7,
      "target": 24
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The up- regulation of nAChRs has also been obtained using nicotinic agonists (cytisine, carbamylcholine and varenicline) [66, 67], antagonists (dihydro-Î²-erythroidine, mecamylamine) [68-70] and a partial agonist (CC4) ",
      "key": "f2c08eff93296d0171e7788b88b629c06f6d8c566dcb08c092182f9e26337223bf52f80db57d69b4fc2db5688403ef972f420242cd8e70b203cf80b8c037abb2",
      "line": 152,
      "relation": "decreases",
      "source": 22,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The up- regulation of nAChRs has also been obtained using nicotinic agonists (cytisine, carbamylcholine and varenicline) [66, 67], antagonists (dihydro-Î²-erythroidine, mecamylamine) [68-70] and a partial agonist (CC4) ",
      "key": "414968c468faeed490fb5e7bf4b976edb9166f0639d1fce2652219e528d00f29f13644afb82e2cf34b00f79289e04ca076d94270692c02e52a97751b360651d0",
      "line": 157,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 22,
      "target": 24
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Dopamine (DA) neurons, which project to the NAc receive both excitatory glutamater- gic and cholinergic afferents that mediate nicotine reward, and inhibitory GABAergic afferents, that mediate aversion [77]. The release of these neurotransmitters is modulated by the nAChRs expressed in cholinergic, glutamatergic and GABAergic terminals ",
      "key": "2e1332ef8cccaa67def3aad3e75151de282395f6ba06534a67ad783363b82e84373b865a5eb5dc798f21fe43b3f3730c1a1c5c73ff02fdca184f63573955e06c",
      "line": 165,
      "relation": "regulates",
      "source": 8,
      "target": 24
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Dopamine (DA) neurons, which project to the NAc receive both excitatory glutamater- gic and cholinergic afferents that mediate nicotine reward, and inhibitory GABAergic afferents, that mediate aversion [77]. The release of these neurotransmitters is modulated by the nAChRs expressed in cholinergic, glutamatergic and GABAergic terminals ",
      "key": "89bba40642383a3ae874594a40c72897ec0d5e929d741c8b942ff4b38bc8ad4c852591ae2008226b2b4724aa3625576b840df2fb4ed89afe9497f822199deada",
      "line": 166,
      "object": {
        "location": {
          "name": "GABAergic Neurons",
          "namespace": "MESH"
        }
      },
      "relation": "association",
      "source": 3,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Dopamine (DA) neurons, which project to the NAc receive both excitatory glutamater- gic and cholinergic afferents that mediate nicotine reward, and inhibitory GABAergic afferents, that mediate aversion [77]. The release of these neurotransmitters is modulated by the nAChRs expressed in cholinergic, glutamatergic and GABAergic terminals ",
      "key": "6cb914525dbcdfdec708b4cc8024e42813f1a4e5d7656b10fe5426fe67d9c524ffa78e5c641fcd9d12c1d577d3f26c00d18d4a146102a34f5cad7aabbe213498",
      "line": 167,
      "object": {
        "location": {
          "name": "Cholinergic Neurons",
          "namespace": "MESH"
        }
      },
      "relation": "association",
      "source": 3,
      "target": 72
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "By acting on the Î±7 receptors in glutamate terminals, acutely administrated nicotine stimu- lates the release of glutamate, which facilitates the burst fir- ing of VTA DA neurons and eventually leads to LTP,and increases the firing rate of the GABAergic neurons of the rostromedial tegmental nucleus",
      "key": "546f1c774089655a3e5a0df30b533e27ae4aa50549690f9d8261d13dd58e708426aae1846549061dac6a658fb7a90102859f8e083354d21e99e703c7d8fc4f33",
      "line": 173,
      "relation": "increases",
      "source": 20,
      "target": 43
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "By acting on the Î±7 receptors in glutamate terminals, acutely administrated nicotine stimu- lates the release of glutamate, which facilitates the burst fir- ing of VTA DA neurons and eventually leads to LTP,and increases the firing rate of the GABAergic neurons of the rostromedial tegmental nucleus",
      "key": "a5c5288485edf39109f3c41d97bcc19ca08e71142257fd6e1ef6c3af34085a95f7d88cb9eb3cd72ab8b6d67fd9b6f040fd1f22614d6e31f50ea68d79f5f71d2e",
      "line": 174,
      "relation": "increases",
      "source": 20,
      "target": 29
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The Hb-IPN system expresses the highest levels and va- riety of nAChR subunits and subtypes in mammalian brain [85], and is the only central system expressing high levels of Î±3, Î²4 and Î±5 subunits. ",
      "key": "a714a1475e5e7578a4902942fc04e6cd09138c38150382b68ec9480d2532c86153895b3b213df55c1aff4897618f5f65b2a05f6835b0631dec95a8975e307d54",
      "line": 195,
      "relation": "increases",
      "source": 37,
      "target": 72
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The Hb-IPN system expresses the highest levels and va- riety of nAChR subunits and subtypes in mammalian brain [85], and is the only central system expressing high levels of Î±3, Î²4 and Î±5 subunits. ",
      "key": "c68adca4dd7df1d167da07b87d0024ffebbeb9628bfd2d963d8d7b0fc3ecf3c487118bcbbf56c30e560eeca054a10780455ef8e32868f31153e866c521944176",
      "line": 196,
      "object": {
        "location": {
          "name": "Central Nervous System",
          "namespace": "MESH"
        }
      },
      "relation": "increases",
      "source": 37,
      "target": 59
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The Hb-IPN system expresses the highest levels and va- riety of nAChR subunits and subtypes in mammalian brain [85], and is the only central system expressing high levels of Î±3, Î²4 and Î±5 subunits. ",
      "key": "edab3c9611b244736bd6b783326e40d2c20f9a4ad644e6bba988fc2a0cabe734bc9af94b1b043b2157a168de74c984c888debc1d78c92c8f96e06bc22d662f9b",
      "line": 197,
      "object": {
        "location": {
          "name": "Central Nervous System",
          "namespace": "MESH"
        }
      },
      "relation": "increases",
      "source": 37,
      "target": 66
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The Hb-IPN system expresses the highest levels and va- riety of nAChR subunits and subtypes in mammalian brain [85], and is the only central system expressing high levels of Î±3, Î²4 and Î±5 subunits. ",
      "key": "c7cd08a350bd2e29be053543e73c453bb9f7865402af80f3f2187ed8eb179528fce1c1db00493ff018be9fca78449ac99420de8162b9a4b57141835faa630dac",
      "line": 198,
      "object": {
        "location": {
          "name": "Central Nervous System",
          "namespace": "MESH"
        }
      },
      "relation": "increases",
      "source": 37,
      "target": 61
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The coding SNP Î±5 D398N is closely associated with nicotine consumption ",
      "key": "e047a797ceb7de209eaa86867947809526da1ee86584367aadd05e29a7ae83d7098cfe2ebaa8edaaf749d17342af4b9c6b898896ce8ade9f72db96c731219aff",
      "line": 201,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 55,
      "target": 24
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Î±5 subunit Ko mice or mice with selective knock down of the Î±5 subunits in the Hb develop increased nicotine intake in a self-administration paradigm that is blocked by the selective re-expression of the Î±5 subunit within the MHb; thus indicating that the Î±5-containing nAChRs located in this brain area also play an important role in regulating the negative effects of nicotine. ",
      "key": "500d5e1f22c7b9cdcccabbcd9ef532b5f547c8ffba0f9312ba0af83bf808ac553ab9fbcbc161995118a67c68735c5f29993c1a932959c0216b436791816202a8",
      "line": 204,
      "object": {
        "modifier": "Activity"
      },
      "relation": "regulates",
      "source": 74,
      "target": 24
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Finally, a study has shown that Î±2 Ko mice have enhanced nicotine self-administration behaviour [88]. These findings suggest that Î±5* nAChRs in the MHb, and Î±2* nAChRs in the IPN may underlie aversive responses to nicotine.",
      "key": "e7b3e34cfe81d0f44f05b221ee9ac4e11099ca8d9f0bf7ab11c177e33555825fdc2a656c363df4c25e9f783a16f02be2d1fc31254a631a1d05f445cf1f181042",
      "line": 210,
      "relation": "increases",
      "source": 74,
      "target": 24
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "On the contrary the overexpression of Î²4* nAChRs in mice decreases nico- tine reinforcing properties and consumption ",
      "key": "e7266e9f5215bb3aaceeaa0e0071b98d3d14cb317405ad4853b78007ea561ad26e25b638e3bfd9d687d8e66cabaaee5001e226193accf43ed762fc0393b49266",
      "line": 207,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 76,
      "target": 24
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Finally, a study has shown that Î±2 Ko mice have enhanced nicotine self-administration behaviour [88]. These findings suggest that Î±5* nAChRs in the MHb, and Î±2* nAChRs in the IPN may underlie aversive responses to nicotine.",
      "key": "8b28dd3d60305c86870c657f48555b7e48c4e912af4effe6ffda2c2409de5d789c4f156cfbff8c02fadcdc4afde7c40ac346a0f339489c4400cca56c949e43d3",
      "line": 211,
      "relation": "increases",
      "source": 73,
      "target": 24
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The cytoplasmic in- crease in calcium triggers the secretion of mitogenic factors and activates the signalling cascades involved in cell prolif- eration, migration and angiogenesis and the inhibition of apoptosis ",
      "key": "ce5371b35b6e102b82841f06f0fcaafc051c293c55590d7d019bf87bb7b30a544227971e81c891c171679a5bba82c23c3e41342d311b73f875f856ffb5eced5e",
      "line": 219,
      "relation": "increases",
      "source": 0,
      "target": 41
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The cytoplasmic in- crease in calcium triggers the secretion of mitogenic factors and activates the signalling cascades involved in cell prolif- eration, migration and angiogenesis and the inhibition of apoptosis ",
      "key": "888c2f08bc635f01678ad29771e59eecb488d36176bf7fa87994539dbf51b66e53bb39387fcef6e759f16584c998cd58092f517a9b395cec99de8e0915d79993",
      "line": 220,
      "relation": "increases",
      "source": 0,
      "target": 40
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "The cytoplasmic in- crease in calcium triggers the secretion of mitogenic factors and activates the signalling cascades involved in cell prolif- eration, migration and angiogenesis and the inhibition of apoptosis ",
      "key": "5c8bb4f6fafb5395564fa70265dd90daf5ef466ad123af441138e3202bddfb5ef80b912d5ca7ad8e07df14bbee552a04535e86d449006148a246a9fb92848d50",
      "line": 221,
      "relation": "decreases",
      "source": 0,
      "target": 46
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Non-neuronal cholinergic signalling uses the same nAChRs as neuronal cholinergic signalling and the nAChRs in both neuronal and non-neuronal networks are modulated by members of the ly-6 family of small proteins related to snake Î±-neurotoxins such as the Î±7 nAChR antagonist Î±Bgtx",
      "key": "5eaf9b4a32b65951fc92d61d81f5413fa23576a569a6552c49c0ebcc8871c426b68acd3bdc13b4f7e5f95416c1175530068f01198207b39fc8fe8e56a8a049f2",
      "line": 224,
      "relation": "regulates",
      "source": 56,
      "target": 72
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "These proteins include Lynx1, a glycophosphati- dylinositol- anchored membrane protein that can form a sta- ble complex, negatively regulates the responses of Î±4Î²2 and Î±7 nAChRs in heterologous systems and enhances the rate and extent of desensitisation of Î±4Î²2 nAChRs, thus acting as a molecular brake on nAChR function ",
      "key": "622ab9daf9c40571058dc317d01f66b7b243351f9a0f75b0ae6a181b846f31a9d6a0398ae9ade2948ccd304413b09146c9116f31cae9bc9d0b345e666d2ed974",
      "line": 227,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 67,
      "target": 52
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "These proteins include Lynx1, a glycophosphati- dylinositol- anchored membrane protein that can form a sta- ble complex, negatively regulates the responses of Î±4Î²2 and Î±7 nAChRs in heterologous systems and enhances the rate and extent of desensitisation of Î±4Î²2 nAChRs, thus acting as a molecular brake on nAChR function ",
      "key": "502528ebb1d2eca6bc91c368ebdcf6d6c64391863690262bd1b55220f3fbefada367dc21ded4151f162b4591a022f8b1aee68469bcb8b7be1fa07003220a699e",
      "line": 228,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 67,
      "target": 62
    },
    {
      "key": "06519dc44bbf4976649e8d9f02603a99140b58d345ecc1eb47776b1fccd82c017c63f49eb23fbcd61371fe2882fcbdbd765bfb6baf19cf7120c17b7b463ea2a1",
      "relation": "hasComponent",
      "source": 51,
      "target": 59
    },
    {
      "key": "965cc9588f8b042b81a60d74d1f5802bb85b114cc856043d443f3ca7c3824b2697d8e58cdb39e32a8b8a51722caa269d1372ddc7a28e4365d40a7ab434de0631",
      "relation": "hasComponent",
      "source": 51,
      "target": 61
    },
    {
      "key": "1f82f1d36f506fa22dfae2f466bfb2b626c79d241584540365be361daffbcd3ca9ab4e79a3e0c308833195c5381a873fc802d95be0e593f42639d0d5cb68feac",
      "relation": "hasComponent",
      "source": 51,
      "target": 64
    },
    {
      "key": "b9e3624172622346bf61d37193b37d04bfb20fcdcdec733e503126f9a3095bc3aaa3169298de6f18c3202094aa1e86c5bb80bcd6b489cc657c492b85048dd39c",
      "relation": "hasComponent",
      "source": 51,
      "target": 66
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Human genetic studies have shown that the non- synonymous coding SNP D398N is associated with lung cancer and nicotine dependence",
      "key": "b367910b933a82cedec586984d250c7ded4a2b3b32a5d6df7746cbdcd92ec30f3f132662cfaf19c25598948bf158e7cb59850b97df261077eede72ccf42998a0",
      "line": 234,
      "relation": "association",
      "source": 54,
      "target": 80
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Human genetic studies have shown that the non- synonymous coding SNP D398N is associated with lung cancer and nicotine dependence",
      "key": "d00b0c878395d02290a3415b1b8bfde4ba7dedbb546f5f032fea2005151ee59966a785930862de1927089e3b6c8377a539e40d10c1976d9cddbe369773acd56c",
      "line": 235,
      "relation": "association",
      "source": 54,
      "target": 82
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Human genetic studies have shown that the non- synonymous coding SNP D398N is associated with lung cancer and nicotine dependence",
      "key": "00bfca70953c0c153f09e14bbfd78a2b574a60d799513320264757433d4e2e9304f55fbe4b2679023818e3243e26d83187bf42b69c40f4713bc56298836c9af0",
      "line": 234,
      "relation": "association",
      "source": 80,
      "target": 54
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Lee et al. [122] have found that Î±9 nAChRs are ubiquitously expressed in many epithe- lial, lung and breast cancer cell lines, most of which also express Î±5 and Î±10 nAChR subunits. Î±9 nAChRs are also present in primary tumour and non-malignant breast tissue obtained from patients, but their expression is higher in breast cancer cells than the surrounding normal tissue.",
      "key": "4c7b9711b555a6bf2af8f6fc719826006351a0b0c04fdcf1d5084b718d6b13f17fa674f807d5beaeaac5055297fd9209c53b6a3b0496ab13210896f9e5e0852e",
      "line": 288,
      "relation": "increases",
      "source": 80,
      "target": 63
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Lee et al. [122] have found that Î±9 nAChRs are ubiquitously expressed in many epithe- lial, lung and breast cancer cell lines, most of which also express Î±5 and Î±10 nAChR subunits. Î±9 nAChRs are also present in primary tumour and non-malignant breast tissue obtained from patients, but their expression is higher in breast cancer cells than the surrounding normal tissue.",
      "key": "b681685f57edcdbc5977ee60709ca07e1f97a449af44b35c02e7b0fb4cefa693793750fa0cc9d7f04eef1bddb9c5c42310fceaa1b3ceae6640fb602932675e4a",
      "line": 290,
      "relation": "increases",
      "source": 80,
      "target": 61
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Lee et al. [122] have found that Î±9 nAChRs are ubiquitously expressed in many epithe- lial, lung and breast cancer cell lines, most of which also express Î±5 and Î±10 nAChR subunits. Î±9 nAChRs are also present in primary tumour and non-malignant breast tissue obtained from patients, but their expression is higher in breast cancer cells than the surrounding normal tissue.",
      "key": "1a07d6743e85a02f5fe89f358ce056c70f9e9e77a02f2c16b80821bd53cef1607e5c2297d4ec1ddae175eb3d3197aa6d836cff8ed94d99ffd29c53e559efa022",
      "line": 292,
      "relation": "increases",
      "source": 80,
      "target": 58
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Human genetic studies have shown that the non- synonymous coding SNP D398N is associated with lung cancer and nicotine dependence",
      "key": "3e295217052199561ffd95220d86376abcf4f4ac5d5238c9ce8210ea97af4f5f68a01cbeba4491773badfa800d21ae7ca4d78b3d460921f6a1154791a1ff45d1",
      "line": 235,
      "relation": "association",
      "source": 82,
      "target": 54
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "In addition, various studies have shown the expression of Î±7 nAChR (as mRNA and protein), in many different cancer cells obtained from human tumours.",
      "key": "16879223b458fc35095e47d8bb5411fe01d7156d286671b615480b7489a77b38d585bfaa96be67808a1bb87c2891272dc2a0b28a74259d7220d732a195601e3d",
      "line": 242,
      "relation": "association",
      "source": 90,
      "target": 62
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "whereas those on microglia increase intracellular calcium levels and signalling cascades without using channel function, and those on macrophages and other immunological cells signal through the JAK2/STAT3 tran- scription factor pathway",
      "key": "93b290d714878bef04f0c024178713a7946f51903a02cff1c97c1eed851904d46d8f721a6b50809657e6acd20cddcb9cef325956c8ac7a8eee9eb7668e22318d",
      "line": 249,
      "object": {
        "location": {
          "name": "intracellular",
          "namespace": "GO"
        }
      },
      "relation": "increases",
      "source": 28,
      "target": 0
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Airway epithelium cells synthesise, store, process, se- crete and reabsorb ACh, which acts as an autocrine and paracrine growth factor ",
      "key": "77edbd2a16e937798e97d4e58238879ba78df5852ca8f4465cf5df1ef4c5789b8799f4295f7a107b2d22ef59587537ae06297d5ce9cc60a10d79595bb4af0183",
      "line": 252,
      "relation": "regulates",
      "source": 18,
      "target": 14
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Î±7 nAChRs are essential for the plasticity of the airway epithelium as Î±7 Ko mice show altered basal cell layer formation, hyperplasia, and uncontrolled growth",
      "key": "ab748a7f719f23e60e4dea38231923234888984ce361680571b9e796cb93b2778b1b58957eaa48b0db983cce21e1ee22bfb30daf16df1b516b93ff0092b87535",
      "line": 258,
      "relation": "association",
      "source": 18,
      "subject": {
        "modifier": "Activity"
      },
      "target": 75
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Î±7 nAChRs are essential for the plasticity of the airway epithelium as Î±7 Ko mice show altered basal cell layer formation, hyperplasia, and uncontrolled growth",
      "key": "733cb86e0794c8e9a2ad06e349956e8b9479405624f75e11474300522d777e2d73fb2233807a9d7f154fb88a1c7f71309aabe12415a2d2618cc0369c1b5e4e0d",
      "line": 258,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 75,
      "target": 18
    },
    {
      "key": "3dbe005fd09a157aa884a02aae3c0659bbf009bcef0aa4f1033e9b5f4140331a91c9c5f74ee6e376c09db67f8c928bca3a45ef8a4133272d67cbee85cbe62eec",
      "relation": "hasComponent",
      "source": 50,
      "target": 58
    },
    {
      "key": "f9a0d44d06280b42306670631563833fa65915f893f3778e7b193281f334507a1c8e0487c80c3040f0394cb8e4efe2e182feafabed1a84f239a7ba00e0a4711a",
      "relation": "hasComponent",
      "source": 50,
      "target": 63
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": " Unlike the Î±9 subunit, the Î±10 subunit is only functional when it is co-expressed with an Î±9 subunit. In Xenopus oocytes, the co-injection of Î±9 and Î±10 subunits increases functional nAChR expression at least 100 times more than the injection of Î±9 alone.",
      "key": "4c0b256b0d97b428ff72b6ddeebffacda221953ba034b9e9b48ad1f9e7e34ac23dd3ace3f9521702994a3065723b52d0db5796438f851212a094c0188da3c622",
      "line": 268,
      "relation": "increases",
      "source": 50,
      "target": 72
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Si- lencing Î±9 nAChR expression in the tumour cells reduces their proliferation and tumorigenic potential in in vitro and in vivo assays [122].",
      "key": "ed2f0149f553c260dca1c4732d7d52ffe91103da3a7c5bbccfef7c1fdf6b4bb26e9522db375665dc8fb9b7174e6a45927de9f81998baa98aba37b8daa31ebb64",
      "line": 296,
      "relation": "increases",
      "source": 63,
      "target": 90
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Î±9 and Î±9-Î±10 nAChRs have a number of interesting characteristics: they are acti- vated by ACh but not by the classical agonist nicotine. Cho- line is also a potent selective agonist of the Î±9 subtype",
      "key": "e211c9b3245d802bd1f1783296c579641fc313bf9813a5b786518b2680d66b1eda5bfc3223ca941335e0a4256a42f3449859b59bf9ed1d88b754bb03019f9fa9",
      "line": 275,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 16,
      "target": 63
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "whereas phosphocholine (PC) does not evoke ion current responses in Xenopus oocytes expressing functional ho- momeric Î±9 or heteromeric Î±9-Î±10 nAChRs [121]. How- ever, preincubation with PC attenuates choline-induced ion current changes, thus suggesting that PC is a silent agonist of these two subtypes ",
      "key": "04ac18557cc3555b3bcb0119c22e2220fc3e594530cc259cb362093477355cd11e36601a65aa57b45fbdf8e33e726820c6d7bcba94f9317b07a7d9ce1079808a",
      "line": 278,
      "relation": "causesNoChange",
      "source": 25,
      "target": 50
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "whereas phosphocholine (PC) does not evoke ion current responses in Xenopus oocytes expressing functional ho- momeric Î±9 or heteromeric Î±9-Î±10 nAChRs [121]. How- ever, preincubation with PC attenuates choline-induced ion current changes, thus suggesting that PC is a silent agonist of these two subtypes ",
      "key": "49412d14b486522c2a01346bf11140af18665ad267fcf26389d3b4c07173d6c291a0b5d10e5a8fcad377f90539af9fa62daca8cbdf44680defb8e12243c851f2",
      "line": 279,
      "relation": "causesNoChange",
      "source": 25,
      "target": 63
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Î±9 or a9 and Î±10 subunits are expressed in most immune cells, dorsal root ganglion cells, human keratinocytes and colon and breast cancer cells. ",
      "key": "e176ac8e7c67fd7a79623bc32f65ad2829f151152a4a0e80ca6d603c71766b80db23f75aec7968e33b3c329088ec002a0c9a996de30674b923db4b914ec7e275",
      "line": 282,
      "relation": "increases",
      "source": 11,
      "target": 50
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Î±9 or a9 and Î±10 subunits are expressed in most immune cells, dorsal root ganglion cells, human keratinocytes and colon and breast cancer cells. ",
      "key": "2c8821fdb4eb5aa4bccc32a6e90cf706fe2e3392cff29f48de2c9eacdb3c61d0c3834a81869095c5cb58570d037f94894037d79fd2dc7914e45781fc7c2ba20c",
      "line": 283,
      "relation": "increases",
      "source": 11,
      "target": 63
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Î±9 or a9 and Î±10 subunits are expressed in most immune cells, dorsal root ganglion cells, human keratinocytes and colon and breast cancer cells. ",
      "key": "cc4c986834e772d5ec2b9eaf8d66d00dc8dca993ad666aa656a5dc92e2db5fcb47f0cf00f5d7de1605de074b0716ae0a65426fdfcbd65b951a334214ba0b11f7",
      "line": 284,
      "relation": "increases",
      "source": 21,
      "target": 50
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Î±9 or a9 and Î±10 subunits are expressed in most immune cells, dorsal root ganglion cells, human keratinocytes and colon and breast cancer cells. ",
      "key": "7a0527019620a6c1b79d1b24be5fec1ad0916217e4465a7081fb1a07d844fd2f693f826b76b0a5b88ccb936916362d28680b6e039e6dc6ad46eaf1543544b71e",
      "line": 285,
      "relation": "increases",
      "source": 21,
      "target": 63
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Lee et al. [122] have found that Î±9 nAChRs are ubiquitously expressed in many epithe- lial, lung and breast cancer cell lines, most of which also express Î±5 and Î±10 nAChR subunits. Î±9 nAChRs are also present in primary tumour and non-malignant breast tissue obtained from patients, but their expression is higher in breast cancer cells than the surrounding normal tissue.",
      "key": "f7c760df6af7c3dbe4b210e0771472758d3c32987dfb0f98cd218352864031884d82c721999d89d134903b5701afc4b43efc1d64cfaff07b9a61b7c605bf3173",
      "line": 289,
      "relation": "increases",
      "source": 78,
      "target": 63
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Lee et al. [122] have found that Î±9 nAChRs are ubiquitously expressed in many epithe- lial, lung and breast cancer cell lines, most of which also express Î±5 and Î±10 nAChR subunits. Î±9 nAChRs are also present in primary tumour and non-malignant breast tissue obtained from patients, but their expression is higher in breast cancer cells than the surrounding normal tissue.",
      "key": "2875289ca0dc9cc409e8dc8e89f56c173c1e33e19f30140363d67107c2564c488ad6ecda9d628ab2f59595e8061743ef1674c3d28d2cd28566e7d7cb9d33a4ea",
      "line": 291,
      "relation": "increases",
      "source": 78,
      "target": 61
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "GABAergic Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Gotti C",
          "Pucci S",
          "Vilella A",
          "Zoli M"
        ],
        "date": "2018-01-01",
        "first": "Zoli M",
        "last": "Gotti C",
        "name": "Current neuropharmacology",
        "pages": "338-349",
        "reference": "28901280",
        "title": "Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.",
        "type": "PubMed",
        "volume": "16"
      },
      "evidence": "Lee et al. [122] have found that Î±9 nAChRs are ubiquitously expressed in many epithe- lial, lung and breast cancer cell lines, most of which also express Î±5 and Î±10 nAChR subunits. Î±9 nAChRs are also present in primary tumour and non-malignant breast tissue obtained from patients, but their expression is higher in breast cancer cells than the surrounding normal tissue.",
      "key": "fb111c6d0e767faad72b038825ec614c1b4e97d910d54997f4b12dd49929539b95faf782afa4aa789cc769f82e93f66bd808ad83067179f7d55e768cae27caa5",
      "line": 293,
      "relation": "increases",
      "source": 78,
      "target": 58
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"calcium cation\")",
      "function": "Abundance",
      "id": "c10ddd67dbfc49f2d2d522209f88bb4316826c90a9b111bea0085da8cfbf08d9cdbaa0b800f0c6ea9e8e9c67d9a69a32825bbd3743c583aed91033410bfeaf60",
      "name": "calcium cation",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"potassium(1+)\")",
      "function": "Abundance",
      "id": "1de6002926900456ea4c9426184872f0e5385e34c1dbb7a1ad64356492c19609f3d3d29a23e11e4ac80ae28bd853b39387fe8713682ae7773e709d420505d006",
      "name": "potassium(1+)",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(HBP:cytisine)",
      "function": "Abundance",
      "id": "615fafc25708f6a39f208c414613c03c5922bbbab4a5ef811aa349018989ea4a608a0bb78e618526af603653b0676fe9da57f7979f648f9b6f26ef0b3ef5c461",
      "name": "cytisine",
      "namespace": "HBP"
    },
    {
      "bel": "a(HBP:neurotransmitters)",
      "function": "Abundance",
      "id": "c21db72d61181c03873c9e6c05c47435b05447cfefab6e56fba26d996263df3a4ce57c620c42c5c2c40bb9635b909a033020998149095c3a1ef9ecbb9ff7b67c",
      "name": "neurotransmitters",
      "namespace": "HBP"
    },
    {
      "bel": "a(MESH:\"Central Nervous System\")",
      "function": "Abundance",
      "id": "1fe0c06a1530f3b8af3f023bf0ce521de8876c8c1b0f155dcea151c3fdd6742554432e6dbb7aa73df3e5bb75d304f288726f4c7510fbbcb0854947b7e2a9763e",
      "name": "Central Nervous System",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"Choline O-Acetyltransferase\")",
      "function": "Abundance",
      "id": "8ecbf39ae6006cc717705d148d78ea60fd7a3c3705f1c43f0dc56d12c4ddbc325ec944824f2067778fcf43e7681724c3ed3f79402ed823885f67c5099c9639ce",
      "name": "Choline O-Acetyltransferase",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"Cholinergic Neurons\")",
      "function": "Abundance",
      "id": "475e93ca136a9e7794a0aa5f656e5e5514ae3be3984ee430b1c69e597fa87e955ab73e3aa428c790e154477727ce382f73ecadc9ea6ee58ce4366c0b4ed73765",
      "name": "Cholinergic Neurons",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"Dihydro-beta-Erythroidine\")",
      "function": "Abundance",
      "id": "ffc5021fdc725a48a185594f5c5bb68b41bcf9e1fb3be46e117db0370bbf7a69a45535d89cc6313079c5fbf573b7a47b35c6c888b499ab029910de98fd0f4989",
      "name": "Dihydro-beta-Erythroidine",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"Dopaminergic Neurons\")",
      "function": "Abundance",
      "id": "33bf5a667c04792d6dbea2f308ab342792bd66ea8986863564b45b8ad252462f5ea440b2c9f2f12b90b991b1a11c0291fe2dc4b4afcad8e9442d3950ed576f6b",
      "name": "Dopaminergic Neurons",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"Endothelial Cells\")",
      "function": "Abundance",
      "id": "dfd7d956011f240f45960b1904cf9251d84b815a4737d037b7daf0c29f69ee6aa13d9ac8f489e1a65df599c1c113dad52b4cd1fee831065e7c46932a7118efe2",
      "name": "Endothelial Cells",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"Epithelial Cells\")",
      "function": "Abundance",
      "id": "28df54e7e214aa9cecc6ac239d51863cab17efb57220454333b8eae02aaa706229eb47afff57806aeb67f8081cd5714a55ed2f3bee27d85e8aa70b492aa660f9",
      "name": "Epithelial Cells",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"Ganglia, Spinal\")",
      "function": "Abundance",
      "id": "0293e67bd3ed20529285eb3b3cb459136df007e35868b021d09b1d284934956fb92648bfe1fe0137fd33661de8fdea660bd0c21e4358f71f40f3e441a21c4f27",
      "name": "Ganglia, Spinal",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"Peripheral Nervous System\")",
      "function": "Abundance",
      "id": "2acf48eee47597ed7ddfd515dfb36be47316a96eab23be32c772671645a86d53ddc3549eb65d6b079fa69e67080f36eec39bcfdcb8983ce613ea97e54103e940",
      "name": "Peripheral Nervous System",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"Receptors, Muscarinic\")",
      "function": "Abundance",
      "id": "0c38c834248f66724abe970a28b58c648d4e6a7d7be75d02439f9a375879f21d530deec055a2579894f9b2eec6e3f3a1e1d26644734f40c45c9d903e41f4248a",
      "name": "Receptors, Muscarinic",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Acetylcholine)",
      "function": "Abundance",
      "id": "9e020dc85a11a30c92b2497436a3887fae49f9424c6b39afca85dc0bec3938998cff2426b2edceaad35239244592cc290dffe5a587823f21da7e012a65241f0f",
      "name": "Acetylcholine",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Carbachol)",
      "function": "Abundance",
      "id": "6a54e94c57fbb2178c2a61dab73d32997b849e1e240ea8d57e95ba4ae85c3c73aac0aefd6c651cc5b447564689bfaf83ae91b948265843674d52abbdaa4bcba2",
      "name": "Carbachol",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Choline)",
      "function": "Abundance",
      "id": "e2bb2b8ab5f3d419e676d958a94bc6032823da7e4be199a0a65fcdffebbdb8b28e65fdedb485fb7b3fddcd1708d8e8cbb6bc0adbfc75760b2d417b2fb1c78033",
      "name": "Choline",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Dopamine)",
      "function": "Abundance",
      "id": "874074898703a9ca0fbf11af0cc35210b61a9f7883aefb5c175580492686143d5581faff742ddc4b6d6b9da68a2b1af0cd01dc8f869268b0a80129b8e8854975",
      "name": "Dopamine",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Epithelium)",
      "function": "Abundance",
      "id": "c1b3e1a6ea5d51c1857d428894e3457b464cfd9d4f7dd87e4e2ba11f20ff0eccddf475a223a55c88f010c5ec441cb27764edfa529e2dc2157f2e029e01e4d8a5",
      "name": "Epithelium",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Erythrocytes)",
      "function": "Abundance",
      "id": "f1ae8bfd0b1d90489a0ec83ae8321f1b74945a47d0f876bdd7890757d90c2bd28c6abd380f82208f2fed3dfebefeb075fe3984415a39289b68ebcb7e2989368c",
      "name": "Erythrocytes",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Glutamates)",
      "function": "Abundance",
      "id": "f2ab9b68392c71d34194c85dc116ac795289303a35af27524b9bcf361fac8d0062824697dc2a47b16fbfbcac9e85abf6d6d0b89254a16c1dc3fc5fd85b13fe9e",
      "name": "Glutamates",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Keratinocytes)",
      "function": "Abundance",
      "id": "2f7670f2d4e647e47d8aab681283f40699206416b4388a8f36ea3dfbd4dd8ed3cf4cdfda5808ad4cda546ec46beb2864c356fd337a417a1bfab1c00440833d36",
      "name": "Keratinocytes",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Mecamylamine)",
      "function": "Abundance",
      "id": "ecf9d1e20fcccd7614256514df89cefa3bd29bdf1e3d8677cf8eaddfe71c90f8bb82f5ff200045b55ba2ad8e2dfe515cd62ec002727ae8b53793b4e4e8cf0ab8",
      "name": "Mecamylamine",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Neurons)",
      "function": "Abundance",
      "id": "130131072f276d163b9e361a4ca4814f1d254907d297db502ccb4f6e75dff10db1f2b384bb435c9b46e91310d585aea1db3108e00905a31bb1388ccda1f0c643",
      "name": "Neurons",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Nicotine)",
      "function": "Abundance",
      "id": "3eb1dbccbb6b2ad9bfd3cac8fc98c63d9aa6c7e37e0fe74f924fbf2d75bd4c9e75649057b84177a0e9636caaf65f642d8cf85fb8c46fc5a362c92c2b4b7cdb30",
      "name": "Nicotine",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Phosphorylcholine)",
      "function": "Abundance",
      "id": "3209ae37f3a17ba1450bb4b39a863637fdd69adeba4cafbe897d9bfa9956d68796768720506df6e9ead3abbaaf5299ccf6f1af2b3c4285b3db9fbbe9c21db183",
      "name": "Phosphorylcholine",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Sodium)",
      "function": "Abundance",
      "id": "a380e37f479a182748ea68c1128b8bab2a779b5e5f9153f1dd0cf9efc8b45f79f84136f487f5ec0bd9714570aa99728f18fa43a03c99001cffa328820c22611a",
      "name": "Sodium",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Varenicline)",
      "function": "Abundance",
      "id": "8e704057745521f3340538901c0f1ab005ad2d518215da4a022a2f03a14378fcea257145782e875672a37f67f75720ea8494523a4d274f7b2205c46ff244e7d6",
      "name": "Varenicline",
      "namespace": "MESH"
    },
    {
      "bel": "bp(GO:\"JAK-STAT cascade\")",
      "function": "BiologicalProcess",
      "id": "6fca26da06dd38e74b7c01ecf8df464e6fa761f0d191c2ccd617a2e5823b2983ec3bca82858a6581682dd2b44bc977e63789c6780734ee3ce42a30d9a2873026",
      "name": "JAK-STAT cascade",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"action potential initiation\")",
      "function": "BiologicalProcess",
      "id": "6f51801f7e712519f75d8699aeffb6f9ac5ae8a8feba5cf3ba5a31d577139528e758d50531ba27e799f3c68a86e5dc61a998a23ac14848a007b70122a89ddbeb",
      "name": "action potential initiation",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"cell adhesion\")",
      "function": "BiologicalProcess",
      "id": "eb7f167e8ffb26350b9a44ef4524e49e56bf02b046c745d061c213cf014b731678f10cd7e9fe942f7838e10a6c24fe051e2b60921b71bf3f9adf5afe60abcb7f",
      "name": "cell adhesion",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"cell differentiation\")",
      "function": "BiologicalProcess",
      "id": "e378d5bbe8a52a68fc572bd2030fce8979ad5c9d2607670a975071a85c3d9fddb232efc8c4bdec36ff80b89256692aa5f9f3bba798b570d2cb31da7e81e05181",
      "name": "cell differentiation",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"cell-cell signaling\")",
      "function": "BiologicalProcess",
      "id": "444d3682cb55f86c231efb8fe9b80acc0a5506dd2ffa65bd03d26bcd31819d480e115cd19a942eecc91998b91b1ae77c7e00785f5600f3a1b6fdf18d5f80c455",
      "name": "cell-cell signaling",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"intracellular receptor signaling pathway\")",
      "function": "BiologicalProcess",
      "id": "15e0ed76c734026aac06907094198ce672b6d4121076d99c36161dfd14350251ee8232cd2dab73d67fccda2f754307e2bb9bf65c94d8586e1a72f5a2e34b6658",
      "name": "intracellular receptor signaling pathway",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"nodal receptor complex assembly\")",
      "function": "BiologicalProcess",
      "id": "d330772b86e4a6e4125a14a7d8499a09afe5657bf5cca095d0460edfa7c11e6fab9b97ff80c7c265f717fdea3fae522a0593c3bd7f7d4f0bc11a4ec8ebfd98b2",
      "name": "nodal receptor complex assembly",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"secretion by cell\")",
      "function": "BiologicalProcess",
      "id": "3aef7e0f67c256c2258058a8098e70009d290eaa41c46e4826efb0ce39026518fc40dae6259b7bd8e5bb4d561a9e60b631ab7994b00dc2fb25360b03de7c9710",
      "name": "secretion by cell",
      "namespace": "GO"
    },
    {
      "bel": "bp(HBP:\"cell population proliferation\")",
      "function": "BiologicalProcess",
      "id": "33aecbd55cddbd303a20c583b8f060d04e34438299ba871eeb8844160ecfd5f636ac470166733deff099386d16eecb934e62318fff6294cb1e88e573690462b7",
      "name": "cell population proliferation",
      "namespace": "HBP"
    },
    {
      "bel": "bp(HBP:\"habenulo-interpeduncular pathway\")",
      "function": "BiologicalProcess",
      "id": "fdaf0d13a45eb0ff05a534cbc81784ee64e0f4746744dac8f1740bf8adae661608bd733aa9cb1040e60a924ff628a02fc3ff13eae4f6cb6aad856a31aa130772",
      "name": "habenulo-interpeduncular pathway",
      "namespace": "HBP"
    },
    {
      "bel": "bp(HBP:\"juxtacrine signaling\")",
      "function": "BiologicalProcess",
      "id": "bbc3ea173f1bd5369268f38866818f5f5820b2f0e5b5ceda6f5015927c79d2391e048f64beda9590b88f45c254c6c95f52c82e879c5ed64b6755a26fcd12f544",
      "name": "juxtacrine signaling",
      "namespace": "HBP"
    },
    {
      "bel": "bp(MESH:\"Autocrine Communication\")",
      "function": "BiologicalProcess",
      "id": "b0a4065db54aa60de37ccef32a1951cdb7a1a29c2bb232e34b4550bd2edde66fc6e07494b78595748808cd10428617af0fa558d27485f7fcbca5ac6941054d89",
      "name": "Autocrine Communication",
      "namespace": "MESH"
    },
    {
      "bel": "bp(MESH:\"Cell Movement\")",
      "function": "BiologicalProcess",
      "id": "4f6124a5feffbaef80815d14f9119cd98a5a8ec05a69bb6385aabeed90c355268bd92ab53f982ebeca85034978a65412e3ae095f1b97f56cd7425bd868ac7e18",
      "name": "Cell Movement",
      "namespace": "MESH"
    },
    {
      "bel": "bp(MESH:\"Cell Proliferation\")",
      "function": "BiologicalProcess",
      "id": "78774ac09ce22370c2e33a2dbfc63f5c3c0f77150811d4fbd3dbc610251398cf3f904682c0279433d5370f87af967ec9d2ec1989a027e0095363fdfb57151c4a",
      "name": "Cell Proliferation",
      "namespace": "MESH"
    },
    {
      "bel": "bp(MESH:\"Cell Survival\")",
      "function": "BiologicalProcess",
      "id": "abeaa000ab588015eac485dd605b78602795a7e237f3b097d8148a27fa3ebcc7a221d318d0399960d9f10cf194fbc9c29f41a2a8ed8c332b09f4b79680170b61",
      "name": "Cell Survival",
      "namespace": "MESH"
    },
    {
      "bel": "bp(MESH:\"Long-Term Potentiation\")",
      "function": "BiologicalProcess",
      "id": "8fd3ed77e808eb724f4d4d35df48944d4a4adb70edfcf0f359766ac280c4a7fc9b47dd99814024ad92c576dd92f48e8bf052f04b303ba1c95ed51052e4a5ada9",
      "name": "Long-Term Potentiation",
      "namespace": "MESH"
    },
    {
      "bel": "bp(MESH:\"Paracrine Communication\")",
      "function": "BiologicalProcess",
      "id": "962a60abf71a83a730e4acd5dd165de2e20e87c3f59ac730da9baf0a04180da8883fbe4925fa85adb004b555d2bb964e5c07d5572ab16c31f25cc08153dec573",
      "name": "Paracrine Communication",
      "namespace": "MESH"
    },
    {
      "bel": "bp(MESH:Analgesia)",
      "function": "BiologicalProcess",
      "id": "e60f9f389a3c1c55351b21aed9e8f36a1f6d17dca5280a1bd75c2e7634f73ab870c1376b09de61f77c666087986ef92442f2bf4ff0b468f9ee3c0f4f2ad8941c",
      "name": "Analgesia",
      "namespace": "MESH"
    },
    {
      "bel": "bp(MESH:Apoptosis)",
      "function": "BiologicalProcess",
      "id": "39c21a5bf990cacd109cd022171f1f8d53f15707601351a2acf509f4f1a1c21650a3be4e5ddc8df4e09a2d236cc4cc03242239c0b4cde5940d3950792f6b9449",
      "name": "Apoptosis",
      "namespace": "MESH"
    },
    {
      "bel": "complex(a(MESH:\"Receptors, Muscarinic\"), a(MESH:Acetylcholine))",
      "function": "Complex",
      "id": "a8c1b97b5a057c793d91bc8e11fa6d2e2834bd798e0954b3dccf5e04abe2dc03553b96997b7e76a20bceda8109e65001cf9b0ffaf19a305ff6158cfedb3fd6e8",
      "members": [
        {
          "bel": "a(MESH:\"Receptors, Muscarinic\")",
          "function": "Abundance",
          "id": "0c38c834248f66724abe970a28b58c648d4e6a7d7be75d02439f9a375879f21d530deec055a2579894f9b2eec6e3f3a1e1d26644734f40c45c9d903e41f4248a",
          "name": "Receptors, Muscarinic",
          "namespace": "MESH"
        },
        {
          "bel": "a(MESH:Acetylcholine)",
          "function": "Abundance",
          "id": "9e020dc85a11a30c92b2497436a3887fae49f9424c6b39afca85dc0bec3938998cff2426b2edceaad35239244592cc290dffe5a587823f21da7e012a65241f0f",
          "name": "Acetylcholine",
          "namespace": "MESH"
        }
      ]
    },
    {
      "bel": "complex(a(MESH:Acetylcholine), p(MESH:\"Receptors, Nicotinic\"))",
      "function": "Complex",
      "id": "4162540722f67f7ac10b2156cb49cda0c1f0abc4af9859d2d42564386f62530472b7c460132c9aeb6b5f73c1481b9e5f601613b6a382b1df3de6488d62fd37b3",
      "members": [
        {
          "bel": "a(MESH:Acetylcholine)",
          "function": "Abundance",
          "id": "9e020dc85a11a30c92b2497436a3887fae49f9424c6b39afca85dc0bec3938998cff2426b2edceaad35239244592cc290dffe5a587823f21da7e012a65241f0f",
          "name": "Acetylcholine",
          "namespace": "MESH"
        },
        {
          "bel": "p(MESH:\"Receptors, Nicotinic\")",
          "function": "Protein",
          "id": "384f0db080d5060ea617c34a3c2e9cea3bf39492b2fe1680a386662031fda04f7072e86999ad20a3bd48bbbdf984025bd484ba04a9ecc90075f09439df1c4588",
          "name": "Receptors, Nicotinic",
          "namespace": "MESH"
        }
      ]
    },
    {
      "bel": "complex(a(MESH:Nicotine), p(MESH:\"Receptors, Nicotinic\"))",
      "function": "Complex",
      "id": "32425f44898f43df868253463625655b3e0f73ce52202a7f3590a7f86e7b09805cc982e419a16fee14f9f73e4e577f921d07b0e990027ed5e7e8dfc2abf1cb40",
      "members": [
        {
          "bel": "a(MESH:Nicotine)",
          "function": "Abundance",
          "id": "3eb1dbccbb6b2ad9bfd3cac8fc98c63d9aa6c7e37e0fe74f924fbf2d75bd4c9e75649057b84177a0e9636caaf65f642d8cf85fb8c46fc5a362c92c2b4b7cdb30",
          "name": "Nicotine",
          "namespace": "MESH"
        },
        {
          "bel": "p(MESH:\"Receptors, Nicotinic\")",
          "function": "Protein",
          "id": "384f0db080d5060ea617c34a3c2e9cea3bf39492b2fe1680a386662031fda04f7072e86999ad20a3bd48bbbdf984025bd484ba04a9ecc90075f09439df1c4588",
          "name": "Receptors, Nicotinic",
          "namespace": "MESH"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:CHRNA10), p(HGNC:CHRNA9))",
      "function": "Complex",
      "id": "813dfa455035120e852362effac97d922ade188d55ccf012863580ac6683d5770d13b606106d943e50e01d520b693c44260a03c7672a4623a0cacc16493da80b",
      "members": [
        {
          "bel": "p(HGNC:CHRNA10)",
          "function": "Protein",
          "id": "0bbc48a8cfa60e08e8a1ba5af2709f120f3f13d715aee919c66261813355c8676197175be8c1904aef415d92c7c0d776e87a2149fc30b3d7f1665158f1c0c645",
          "name": "CHRNA10",
          "namespace": "HGNC"
        },
        {
          "bel": "p(HGNC:CHRNA9)",
          "function": "Protein",
          "id": "8d5d3a89881c31692ed5f732b23bf994b16f9ac57317f45527031b0c2258040a2761bf4bb5132efa27de3f9d8dfa9d0950b3d1a094913610ff2bc9b8d01e8c04",
          "name": "CHRNA9",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:CHRNA3), p(HGNC:CHRNA5), p(HGNC:CHRNB2), p(HGNC:CHRNB4))",
      "function": "Complex",
      "id": "8e4dddff294696c416c3c18802c4db62dea1aa9bdbafb0326d042d9d1a4eb804e84faab7db2fce399216d9d416a84d02dfd9a624d09bfc70f6c1c30d7454cee3",
      "members": [
        {
          "bel": "p(HGNC:CHRNA3)",
          "function": "Protein",
          "id": "6f78ff6a0f6731184d18899c2d440e5a27e7d27df60a82118f44199252b2aaac56d93dc20fb99caf759ea575a26ffe4179b16e056eea94d72bb48e24ab188c2c",
          "name": "CHRNA3",
          "namespace": "HGNC"
        },
        {
          "bel": "p(HGNC:CHRNA5)",
          "function": "Protein",
          "id": "615cec2665d995fe2c996d1183a4728e324f4b0f6225b7b3c5f0a0543ff18b97454ba99ae0984cf85ff27bb465eaa83c00cd65aefa96193d58a3332751cca192",
          "name": "CHRNA5",
          "namespace": "HGNC"
        },
        {
          "bel": "p(HGNC:CHRNB2)",
          "function": "Protein",
          "id": "fe8a0d337c8dfad7d9bbfcd38db3a76bbbfa276ae7af2e39600a1b845049505e52dd605173e1b8a8b67178c31bb8cde3f2669676e398c994800c15170b63033e",
          "name": "CHRNB2",
          "namespace": "HGNC"
        },
        {
          "bel": "p(HGNC:CHRNB4)",
          "function": "Protein",
          "id": "54a4217f39d22f6dab3931757d3288776dce65f089209e15d5c6b0a31c7346fc28b6bd9fd28653945fa42712c1e563e6e62e9b484a4896e5f385b0248ac2f9ea",
          "name": "CHRNB4",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:CHRNA4), p(HGNC:CHRNB2))",
      "function": "Complex",
      "id": "d4fd90112c85c79fe7510d181fe801440ce05ef1193b78089fca9732d1e118ae19ab42d218393e25a7f515dceefd26f86d0465e72ea9ec47542be18ef8ca49c7",
      "members": [
        {
          "bel": "p(HGNC:CHRNA4)",
          "function": "Protein",
          "id": "c49a9652cba613af55ca7c03c108df12ef9ea4e37760fcb7b2302e019899a0eaa11f06c1dcd9b9eb143b9baba0daa89737d73dafbfde9d8ddd8dd53b2a8269e0",
          "name": "CHRNA4",
          "namespace": "HGNC"
        },
        {
          "bel": "p(HGNC:CHRNB2)",
          "function": "Protein",
          "id": "fe8a0d337c8dfad7d9bbfcd38db3a76bbbfa276ae7af2e39600a1b845049505e52dd605173e1b8a8b67178c31bb8cde3f2669676e398c994800c15170b63033e",
          "name": "CHRNB2",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:CHRNA5), p(HGNC:CHRNA7), p(HGNC:CHRNB2), p(HGNC:CHRNB3), p(HGNC:CHRNB4))",
      "function": "Complex",
      "id": "7877e5228317f849c04e0b22845c6f1f59ee2e1c183f1f715acb718a46f10967dee61033d5f52995e3fc8667f48b0624fa962d939ea5a627cd762e8825c2fe89",
      "members": [
        {
          "bel": "p(HGNC:CHRNA5)",
          "function": "Protein",
          "id": "615cec2665d995fe2c996d1183a4728e324f4b0f6225b7b3c5f0a0543ff18b97454ba99ae0984cf85ff27bb465eaa83c00cd65aefa96193d58a3332751cca192",
          "name": "CHRNA5",
          "namespace": "HGNC"
        },
        {
          "bel": "p(HGNC:CHRNA7)",
          "function": "Protein",
          "id": "6f517aad2a254d42d4e0bd5118246057049b85324ab857629d0caa2da5e997bfcc08f9a0a2cd83bbb2b536c048ce402c0d521604c43b1b9c720f4e20b4dacd99",
          "name": "CHRNA7",
          "namespace": "HGNC"
        },
        {
          "bel": "p(HGNC:CHRNB2)",
          "function": "Protein",
          "id": "fe8a0d337c8dfad7d9bbfcd38db3a76bbbfa276ae7af2e39600a1b845049505e52dd605173e1b8a8b67178c31bb8cde3f2669676e398c994800c15170b63033e",
          "name": "CHRNB2",
          "namespace": "HGNC"
        },
        {
          "bel": "p(HGNC:CHRNB3)",
          "function": "Protein",
          "id": "cab3d2b7a9a4321d552b5fbe2ff10363ec8ef4b6600f91369ec41f7131fc6d427e0b159e6626d5c42f2eea7b9c11390fc4a6b2964471ee70776ea8960135e7ca",
          "name": "CHRNB3",
          "namespace": "HGNC"
        },
        {
          "bel": "p(HGNC:CHRNB4)",
          "function": "Protein",
          "id": "54a4217f39d22f6dab3931757d3288776dce65f089209e15d5c6b0a31c7346fc28b6bd9fd28653945fa42712c1e563e6e62e9b484a4896e5f385b0248ac2f9ea",
          "name": "CHRNB4",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "g(DNSNP:rs1051730)",
      "function": "Gene",
      "id": "987ffd0cda70869dadcda80e1f4b9be63e135c020d35dfcca126f13b3c6273a8eae630120d3be84db6dde87dae8945c8b38bdb747740e49198b033a628bbf719",
      "name": "rs1051730",
      "namespace": "DNSNP"
    },
    {
      "bel": "g(DNSNP:rs16969968)",
      "function": "Gene",
      "id": "5bca3e3789ae8f122ed1f09aa5b2c43edc1e048d7a1d80797bf4bdda2a8f7f76e55084aec81cab0a76a1c1ef32f14ee8b3ba0ee77554a60ddc1ea6b0bb188d33",
      "name": "rs16969968",
      "namespace": "DNSNP"
    },
    {
      "bel": "p(HBP:\"LY6 family\")",
      "function": "Protein",
      "id": "de14a6521374a6946abedc3f987f015f598c4856b3fe7c23396c336c0eab589707d22de2079d2d53f7ef598f400082259e3dad168c197181c07d17303fff4369",
      "name": "LY6 family",
      "namespace": "HBP"
    },
    {
      "bel": "p(HGNC:CHRFAM7A)",
      "function": "Protein",
      "id": "0178b11148f3fb514eb170df6df4cf5c3995edcb859fb33378587fa2c9830388d1d78761d351e091d737d95515fe8fd34e0a7d480894ced845bb9a6d6ab2a80b",
      "name": "CHRFAM7A",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CHRNA10)",
      "function": "Protein",
      "id": "0bbc48a8cfa60e08e8a1ba5af2709f120f3f13d715aee919c66261813355c8676197175be8c1904aef415d92c7c0d776e87a2149fc30b3d7f1665158f1c0c645",
      "name": "CHRNA10",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CHRNA3)",
      "function": "Protein",
      "id": "6f78ff6a0f6731184d18899c2d440e5a27e7d27df60a82118f44199252b2aaac56d93dc20fb99caf759ea575a26ffe4179b16e056eea94d72bb48e24ab188c2c",
      "name": "CHRNA3",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CHRNA4)",
      "function": "Protein",
      "id": "c49a9652cba613af55ca7c03c108df12ef9ea4e37760fcb7b2302e019899a0eaa11f06c1dcd9b9eb143b9baba0daa89737d73dafbfde9d8ddd8dd53b2a8269e0",
      "name": "CHRNA4",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CHRNA5)",
      "function": "Protein",
      "id": "615cec2665d995fe2c996d1183a4728e324f4b0f6225b7b3c5f0a0543ff18b97454ba99ae0984cf85ff27bb465eaa83c00cd65aefa96193d58a3332751cca192",
      "name": "CHRNA5",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CHRNA7)",
      "function": "Protein",
      "id": "6f517aad2a254d42d4e0bd5118246057049b85324ab857629d0caa2da5e997bfcc08f9a0a2cd83bbb2b536c048ce402c0d521604c43b1b9c720f4e20b4dacd99",
      "name": "CHRNA7",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CHRNA9)",
      "function": "Protein",
      "id": "8d5d3a89881c31692ed5f732b23bf994b16f9ac57317f45527031b0c2258040a2761bf4bb5132efa27de3f9d8dfa9d0950b3d1a094913610ff2bc9b8d01e8c04",
      "name": "CHRNA9",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CHRNB2)",
      "function": "Protein",
      "id": "fe8a0d337c8dfad7d9bbfcd38db3a76bbbfa276ae7af2e39600a1b845049505e52dd605173e1b8a8b67178c31bb8cde3f2669676e398c994800c15170b63033e",
      "name": "CHRNB2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CHRNB3)",
      "function": "Protein",
      "id": "cab3d2b7a9a4321d552b5fbe2ff10363ec8ef4b6600f91369ec41f7131fc6d427e0b159e6626d5c42f2eea7b9c11390fc4a6b2964471ee70776ea8960135e7ca",
      "name": "CHRNB3",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CHRNB4)",
      "function": "Protein",
      "id": "54a4217f39d22f6dab3931757d3288776dce65f089209e15d5c6b0a31c7346fc28b6bd9fd28653945fa42712c1e563e6e62e9b484a4896e5f385b0248ac2f9ea",
      "name": "CHRNB4",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:LYNX1)",
      "function": "Protein",
      "id": "6879c0cb49045a78ce651e62530517b71b93a9301597b3de2d0a356249047afb61fca7ce1a2065d0cdfeeabcc39602d193d4f7a15ffc1da3933f273309402037",
      "name": "LYNX1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(MESH:\"Cysteine Loop Ligand-Gated Ion Channel Receptors\")",
      "function": "Protein",
      "id": "6c8ce4c92f07f2251f1eac894520da5757ec4b5fc774a87d7ce00ea61995f0fad593d836ed1a1878154c1682eba9b81b562a14311ca0bb6ff8f3abec59fd0a10",
      "name": "Cysteine Loop Ligand-Gated Ion Channel Receptors",
      "namespace": "MESH"
    },
    {
      "bel": "p(MESH:\"Proteasome Endopeptidase Complex\")",
      "function": "Protein",
      "id": "7ba913907860a334aa2c868b710d4ba78f0c4d27172ba232c13938356999b1be0fe80be0fe9a151bf7bcc2651967bd674b0ad59b7a893c3c6c032387e4417ef8",
      "name": "Proteasome Endopeptidase Complex",
      "namespace": "MESH"
    },
    {
      "bel": "p(MESH:\"Receptors, GABA\")",
      "function": "Protein",
      "id": "025dedd0505b8bac2a2f2a5e9e8636fb634138e021f4ac3ba9f7578d89cc335869bd021b0975efc9a2fb7f7ed92783da83f4b321797c42a224e34079b5cb3314",
      "name": "Receptors, GABA",
      "namespace": "MESH"
    },
    {
      "bel": "p(MESH:\"Receptors, N-Methyl-D-Aspartate\")",
      "function": "Protein",
      "id": "ab91a476fe132c4c83d7b29153f974577ea615b5e5d8b9bf9e0fa9837b4c78ab8faeb90157fee0678d87fae0d5d4a5ceed372d81c6cf0b12f81ea0faf35d858d",
      "name": "Receptors, N-Methyl-D-Aspartate",
      "namespace": "MESH"
    },
    {
      "bel": "p(MESH:\"Receptors, Nicotinic\")",
      "function": "Protein",
      "id": "384f0db080d5060ea617c34a3c2e9cea3bf39492b2fe1680a386662031fda04f7072e86999ad20a3bd48bbbdf984025bd484ba04a9ecc90075f09439df1c4588",
      "name": "Receptors, Nicotinic",
      "namespace": "MESH"
    },
    {
      "bel": "p(MGI:Chrna2)",
      "function": "Protein",
      "id": "18bf4e2856e868dfd2c2618e4d7aca476a221616ed587036bfea098fa66b57d56f2898695cfd22f3c9ad8e66da2d27100d4991a3349f348f6171dec963be1818",
      "name": "Chrna2",
      "namespace": "MGI"
    },
    {
      "bel": "p(MGI:Chrna5)",
      "function": "Protein",
      "id": "48e97387b5cd70283443508afee81c17115715cae5b87fba00ac95635d08678823156fa1587da533e9fed97bb5e928fa4014f888c92358b60b0b2a9c972e59b8",
      "name": "Chrna5",
      "namespace": "MGI"
    },
    {
      "bel": "p(MGI:Chrna7)",
      "function": "Protein",
      "id": "507ee2a4a31335902e30c31717eb51a26ee9f31d8e015d2cc3beb6961c3c386edb03a4ac82b8c0c0ee38319e2f43609932215b67a7fb2b3e4a496eda6f99f478",
      "name": "Chrna7",
      "namespace": "MGI"
    },
    {
      "bel": "p(MGI:Chrnb4)",
      "function": "Protein",
      "id": "096e40115fb4cadae5f68260b8d3f58395a9a5c916a8dad1cb340aac07d542214e586645638de73175a0e467f3766be394438cef4be2389b5572e37bd4a6aa65",
      "name": "Chrnb4",
      "namespace": "MGI"
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "function": "Pathology",
      "id": "00f72839b5d655cb4cb088b0eb8874bd406284d98a2afd0bdd73de0a34adb78af374b0eb26990387f41d3b41cda0e32c1b5ff5f86ed63d0fdc841bac17865541",
      "name": "Alzheimer Disease",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Breast Neoplasms\")",
      "function": "Pathology",
      "id": "c7e5f7b00302ba04b9046b05bd4dc0a062bcdc73b80b720bf782e5e3d9441f1e3939ae87655af6cc54ce70f1955e32c4b38c9b9ac7201ab00e62dfc8a942d474",
      "name": "Breast Neoplasms",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Cognition Disorders\")",
      "function": "Pathology",
      "id": "43422cbce58332f9de0fad425a85437caaae9bda4848ed4e20f1457b900029d28d1983e193feb851085642fe9280a8338424746eb3afb8b094942401f9a0c969",
      "name": "Cognition Disorders",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Lung Neoplasms\")",
      "function": "Pathology",
      "id": "d92e9bff009ed76caf4716b8e43be58be2ab9f8ccefeb4a114b2f09967cb7912baf173efea2afc5fc28674ede07d2eb6cf2f496570caa8af04c5ed0804983d6c",
      "name": "Lung Neoplasms",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Parkinson Disease\")",
      "function": "Pathology",
      "id": "d7f039170f83b3fcc27595412f3b0352cd1fe95f8481a2b1144ce311ac81bb5f0087a0a7e682f498d193e00b8e8fb29908a6e0b8e23da5ef349aeeb4723b9be0",
      "name": "Parkinson Disease",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Tobacco Use Disorder\")",
      "function": "Pathology",
      "id": "392154e60924d158b0c810d41e3e42cac347e491868ef12dfc2b58986ab7e17c449b76b78e85701b9c9f6e1da60d2392326f78de40e0f6028c713092feda525f",
      "name": "Tobacco Use Disorder",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Anxiety)",
      "function": "Pathology",
      "id": "28f6f3390e4ae722f1c1298abe2059a3e03a8a2de93e506a747733d9e980ed28bb2feb1074ec430fda167d3f38e3c1d930e10c16e5e04f371938ce866caba0dc",
      "name": "Anxiety",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Arousal)",
      "function": "Pathology",
      "id": "6ef612dbaaa09cdc75717ac036d0e0e14c676f92570b19ba659e80dcd0d16f2b523447f2efad61138c062bc54b2b0b71746373d1b6cb093174bf13a46624f27c",
      "name": "Arousal",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Depression)",
      "function": "Pathology",
      "id": "1db8d744eac9b5ac408852b1889bb0b09e0054ea091932f1aa44aeeab0ea1b3825912c55c72fb2d25d5848e77d62b1c6a1df2063a2f25ae03e5ca30085922799",
      "name": "Depression",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Epilepsy)",
      "function": "Pathology",
      "id": "309287b0127e543335c9af55c3e86d48efd9edc5986c0b2b003993d599ad1265556f61abfbbf374e7d73a2cfdf66edb8363ca959d460752bb82144ea8760a90a",
      "name": "Epilepsy",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Inflammation)",
      "function": "Pathology",
      "id": "3196cc4c6a20279c822cae925a9b271d0224f2c8d468e3069a3ee460662be286b61db2f144c550686a9c624e58af4ffa7570f4f2384e1cb8ee40496f8cb3fa5e",
      "name": "Inflammation",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Learning)",
      "function": "Pathology",
      "id": "16476ee53fa25dc5b57c358c9d5d2db6c59c2408db18d1b948d8fefc3acd8203a051b9022ff58a836453c49ed535aaa983401fbe3779e160ade1a4c59424a15b",
      "name": "Learning",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Memory)",
      "function": "Pathology",
      "id": "458f0dcf7b803807dba1023338bdb4a2f225d390c38b33a8972f9ff63b677d58adabbb4ad1bd00d2986334b90861fc40c133593b338b3873bf033d5e09af1322",
      "name": "Memory",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Neoplasms)",
      "function": "Pathology",
      "id": "3acf430fb763193b79a4e43ffc2cbe0822fcb8cb68c26ff93e614c1d6a7dc63fd8afca2116db60243419623d330c5085b60e421eccd5406ac8edf17d2340b500",
      "name": "Neoplasms",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Pain)",
      "function": "Pathology",
      "id": "7c892602ec0888a53b7e5325e40732d94a33e4074ea60461ff7fd223bd15bf9b1565c0b2069497dc15ce86e489f9ddf69baa3101578567cae0fb9f81dbaa8e1a",
      "name": "Pain",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Reward)",
      "function": "Pathology",
      "id": "3acdb51bc32e65d66c5dead4c1340e76c470d1f14ac936fce6488097dbf7e203d06e803fd8f6e80e34905c166f5c0bc694d9663720b30ec9fe94cf04231c1213",
      "name": "Reward",
      "namespace": "MESH"
    },
    {
      "bel": "r(HGNC:CHRFAM7A)",
      "function": "RNA",
      "id": "a8a6f1d7ca39d4e8caba7e3f18d43ad571e52ab6082d921bc97ef14fba4c3d3e7b4e65c09fc0991106e149b3b7fafddb651ee7dcf366e963479c40ff5821041e",
      "name": "CHRFAM7A",
      "namespace": "HGNC"
    }
  ]
}